











Title of Document: NON-O157 SHIGA TOXIN-PRODUCING 
ESCHERICHIA COLI: PRESENCE IN FOOD, 




 Wenting Ju, Doctor of Philosophy, 2013 
  
Directed By: Professor, Jianghong Meng 
Department of Nutrition and Food Science 
 
 
Non-O157 Shiga toxin-producing Escherichia coli (STEC) are emerging 
foodborne pathogens that can cause life-threatening hemolytic uremic syndrome 
(HUS) as well as foodborne outbreaks worldwide.  Compared with O157, non-O157 
STEC are not well studied. The objective of this study is to determine the presence of 
non-O157 STEC in food, identity virulence markers to distinguish highly pathogenic 
strains and determine its phylogenetic relationship. 
Ground beef (259) and pork (231) samples were collected weekly for one year 
period (2009-2010) to determine the prevalence of non-O157 in retail meat in the 
Washington, D.C., area.  Colony hybridization was used to identify potential non-
O157 STEC after PCR screening for the stx gene from the enrichment broth. Non-
O157 isolates were characterized phenotypically and genotypically by serogrouping, 
virulence genes, pulsed-field gel electrophoresis (PFGE), cytotoxicity assay and 
  
antimicrobial susceptibility assay. The results demonstrated that both ground beef and 
pork were contaminated with heterogeneous non-O157 STEC at similar levels (5%) 
and a subset of isolates were potential human pathogens based on the virulence genes 
and serogrouping information. In addition, this study demonstrated that antimicrobial 
resistance was common in STEC isolates from retail meat.  
Additionally, the distribution of pathogenicity islands (OI-122, OI-57, OI-
43/48 and high pathogenicity island) was investigated in 98 STEC strains classified 
into 5 seropathotypes. PCR-RFLP was used to determine eae and stx subtypes, and 14 
PCR assays were used to amplify virulence marker genes of PAIs. In addition, 
phylogenetic dendrograms were constructed for pagC and iha. The prevalence of OI-
122 and OI-57 was significantly higher in seropathotypes associated with severe 
diseases and outbreaks than in other seropathotypes (P<0.0001). Most virulence 
genes located on OI-122, OI-43/48 and OI-57 were found more often in 
seropathotypes associated with severe disease and outbreak than in other 
seropathotypes (P<0.0001). Interestingly, OI-122, OI-57 and OI-43/48 were found 
highly associated with eae-positive STEC strains, while the presence of HPI mostly 
occurred independently of eae presence.  
Last, the phylogenetic relationship of non-O157 STEC was determined based 
on whole genome wide study of 33 STEC and 10 other pathogenic E. coli. 
Dendrogram of PFGE, MLST and whole genome level single nucleotide 
polymorphisms indicated that O26:H11 and O111:H11 were closely related and may 
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CHAPTER I: LITERATURE REVIEW 
E. coli are Gram negative, short rod, and facultative anaerobic bacteria (1). 
Optimal growth of E. coli could be reached at 37 ℃, but it also can grow well at 42 ℃ 
(1). The main niches of E. coli are the intestinal tract of humans and warm-blooded 
animals, where they appear almost ubiquitously. Most E. coli are commensal bacteria 
and do not cause any disease except to immunocompromised people. However, 
during evolution, certain subsets of E. coli acquire a combination of virulence genes 
and become human pathogenic strains. Until now, six main pathotypes of 
diarrheagenic E. coli have been identified based on their virulence genes, pathogenic 
mechanisms and clinical symptoms. The six pathotypes associated with disease are 
enteropathogenic E. coli (EPEC), enterotoxigenic E. coli (ETEC), Shiga toxin-
producing E. coli (STEC), enteroinvasive E. coli (EIEC), enteroaggregative E. coli 
(EAEC) and diffuse-adherent E. coli (DAEC).  Recently, an emerging pathotype 
called Shiga toxin-producing EAEC has been identified that harbors a combination of 
virulence factors from STEC and EAEC. Of all pathogenic E. coli, STEC are the 
most devastating and a major public health concern for its association with large 
foodborne outbreaks and life-threatening hemolytic uremic syndrome (HUS) (2). 
Shiga toxin-producing E. coli: an overview 
 
Shiga toxin-producing E. coli (STEC) are E. coli producing one or more Shiga 
toxin (s). STEC can also be called Verocytotoxin-producing E. coli (VTEC) for its 
toxigenic effect to Vero cells (3). Generally speaking, STEC is primarily used in the 




of diseases such as watery diarrhea, bloody diarrhea, hemorrhagic colitis (HC), and 
HUS. Most of the time, STEC infections are self-limiting; however 5-10% of diarrhea 
infection develop into a potential life-threatening HUS 
(http://www.cdc.gov/ecoli/general/index.html/). The STEC causing HC and HUS are 
also called enterohemorrhagic E. coli (EHEC) (4). All EHEC are pathogenic, whereas 
not all STEC are pathogenic to human beings.  E. coli O157:H7 are the most well-
known serotype of STEC because of its strong association with outbreaks and HUS. 
However, non-O157 STEC can also cause human infection and some serotypes, such 
as O26, are considered as virulent as O157. In total, more than 470 serotypes of 
STEC have been isolated from humans; yet, less than 10 groups are responsible for 
the majority of cases (1). For example, in the United States, six of the most common 
serogroups (O157, O26, O111, O121, O45 and O145) made up 82% of non-O157 
human isolates in 2009 (5).  
Serotyping and seropathotypes  
 
Serotyping is one of the most extensive methods used to characterize E. coli. 
Serotyping is based on the immunologic reactivity of two surface structures: cell wall 
polysaccharide (LPS) (O antigen) and flagella (H antigen).  O antigen determines 
serogroup of a strain, and H antigen identifies its serotype. In total, there are 174 O 
antigens (numbered from 1 to 181, with 31, 47, 67, 72, 93, 94, and 122 deleted) and 
53 H antigens that have been identified with various O and H combinations (1).  
Karmali classified all STEC into five seropathotypes based on a specific 
serotype’s association with diarrhea, HUS, and outbreak (6). Seropathotype A (SPT 




STEC and they are commonly associated with foodborne outbreak and severe disease. 
Seropathotype B (SPT B) consists of O26:H11, O103:H2, O111:H8/NM, O121:H19, 
and O145:NM. Strains in SPT B can cause severe disease and outbreaks similar to 
SPT A, but occur at lower frequency. Seropathotype C (SPT C) is composed of 
serotypes that are infrequently implicated in sporadic HUS and rarely associated with 
outbreaks such as O91:H21, O113:H21, O45:H2. Seropathotype D (SPT D) is 
composed of numerous serotypes that have been implicated in sporadic cases of 
diarrhea, but never in HC and HUS. Seropathotype E (SPT E) is composed of the 
many STEC serotypes that are mainly isolated from animal and food products and 
have not been implicated in human disease (1). 
Although serotyping is often regarded as the starting point of STEC 
characterization, there are many disadvantages of this technique. First of all, the 
serotyping process is tedious and lab intensive. Second, cross-reaction also happens 
between different serotypes and gives confusing results. Third, it is common that O 
and H antigens cannot be serotyped because they are not within the international 
scheme. Last, only a small number of labs worldwide are authorized for E. coli 
serotyping, which makes it not accessible for some researchers. 
Although serotyping can be used to reveal the diversity of STEC, it is often 
not effective enough to distinguish STEC strains. Thus, subtyping methods beyond 
the level of serotyping are needed for epidemiological study, outbreak investigation 
and early detection of geographical distribution of foodborne pathogens. A variety of 




sequence typing (MLST), multiple locus variable-number tandem repeat analysis 
(MLVA)  and  phage typing, have been developed to differentiate STEC.  
Non-O157 STEC: underrated pathogens  
 
It is well known that O157 causes most of the STEC HUS infections and 
foodborne outbreaks worldwide.  However, more and more data show that non-O157 
STEC are as important as O157 and illnesses caused by non-O157 are rising 
worldwide (7). In the United States, the active surveillance of non-O157 began in 
2001. Since then, the number of cases caused by non-O157 is increasing sharply. 
According to recent surveillance by the Center for Disease Control and Prevention 
(CDC), non-O157 can cause almost twice as much infection as O157:H7.  
Specifically, O157:H7 and O157:NM cause about 63,153 cases of diseases annually 
and non-O57 STEC can cause 112,752 cases each year (8). In the Netherlands, survey 
data has shown that 80% of STEC infections are caused by non-O157 (9). Similarly, 
74% of STEC infections are non-O157 in Denmark (10).  However, the real number 
of diseases caused by non-O157 STEC may still be underestimated. Currently, there 
are only a few public health clinical labs routinely looking for them (11).  In addition, 
the isolation of non-O157 is time consuming and lab intensive, and there is no 
biochemical maker that can distinguish non-O157 from commensal E. coli, which 
makes isolation of non-O157 a big challenge. An enhanced surveillance targeting 
STEC by comprehensive laboratory analysis that reported that non-O157 STEC 
increased from < 1 to 11 cases/year/100,000 populations, supported that non-O157 is 




Outbreak caused by non-O157 STEC  
 
The first recorded outbreak caused by non-O157 STEC occurred in Japan in 
1984, and O145:H- was determined to be the causing serotype; however, the source 
of  the outbreak was not identified (12). After this, outbreaks of non-O157 have been 
reported worldwide, including in the United States, Europe, Australia, and Japan. 
There have been more than 80 outbreaks worldwide associated with non-O157 since 
1984 (13). The real number of outbreaks caused by non-O157 is likely more, because 
it is very hard to isolate and characterize non-O157 STEC from food and clinical 
samples.  
 In the United States, there were at least 24 outbreaks associated with non-
O157 from 1990 to 2011 (5, 14).  The first outbreak caused by non-O157 was 
reported in 1990 in Ohio.  O111:NM was the serotype that caused a family outbreak, 
and the source of the outbreak was unknown (15). The largest non-O157 STEC 
outbreak in the United States was also caused by O111:NM; it occurred in Oklahoma 
in 2008. The outbreak led to 341 cases of illness: 26 patients developed HUS and 1 
death occurred (16). Although the outbreak was traced back to a restaurant, an 
extensive effort has been made to identify the source, but no particular source has 
ever been identified (16).  
Although some of the sources are not determined, the main transmission 
vehicles of non-O157 STEC associated outbreaks are food, water and person-to-
person transmission. The food vehicles included milk, salad bars, beef, beef sausages, 
apple cider, lettuce, ice cream and sprouts (5). The serogroups associated were O111 




Virulence factors  
 
Shiga toxin 
Shiga toxin is the primary virulence factor of STEC.  Shiga toxin can be 
divided into two groups: Stx1 and Stx2. The Stx1 group is highly homogenous and 
consists of Stx1a, Stx1c and Stx1d (17, 18), whereas the Stx2 group contains several 
variants including Stx2a, Stx2b, Stx2c, Stx2d, Stx2dact, Stx2e, Stx2f and Stx2g (19-
24). Although Stx1 and Stx2 share a common receptor and have the same intracellular 
mechanism of action, they only share 56% identity at the amino acid level (25). The 
Stx2 variants share about 84%-99% similarity to Stx2a (25). Shiga toxin types and an 
association with the clinical symptoms of STEC infection have been demonstrated 
(26). Stx2a, Stx2c and Stx2dact were demonstrated with high pathogenic STEC and 
the ability to cause HUS, whereas Stx1a, Stx1c, Stx2e and other Stx subtypes 
occurred mainly in patients with milder diarrhea, asymptomatic carriers or in animals 
(26).  
Stxs are encoded by temperate lambdoid phages inserted at various positions 
within the STEC chromosomes (7). Phages are highly mobile genomic elements, and 
play an important role for horizontal gene transfer and diversification of bacteria 
genomes. Stxs are highly expressed when the lytic cycles of phage is induced (25).  
The production of Stx is regulated by several factors such as promoter activity, 
amplification of the copy number and toxin release (27). Once assembled, the final 
toxin secretion is achieved by lysis of the host cells.   
Shiga toxins are AB5 toxins. The A subunit (32 kDa) of the toxin possesses 




protein synthesis of the host cells, and leads to apoptosis. B pentamer (7.7 kDa per 
unit) binds to the receptor molecular globotriaosylceramide (Gb3) or 
gloctetraosylceramide (Gb4)(stx2e) located at the cell membrane (28). The A subunit 
and B subunit are linked through a disulfide bond. The toxin molecule is taken up into 
the cell through receptor-mediated endocytosis. Shiga toxin can be destroyed if the 
toxin carrying vesicle fuses with the lysosome. In susceptible cells, the toxin can be 
transported to the Golgi apparatus and endoplasmic reticulum, leading to cell 
apoptosis. In humans, STEC mainly colonizes the large intestine. Although the 
detailed mechanism is unknown, Shiga toxin can be transferred to the blood stream 
and disseminated to other organs that express Gb3.  Binding sites in human tissue 
include kidney tubules, intestinal lymphoid aggregates, sinusoidal liver cells, alveolar 
macrophages, and peripheral blood leukocytes (29). Renal glomerular endothelium 
cells can express high levels of Gb3 in humans, which is the main reason that STEC 
infection can lead to kidney failure.  
Intimin 
Intimin, which is a 95 kDa outer membrane protein encoded by the eae gene, 
is associated with intimate attachment of STEC to intestinal epithelial cells (13). Two 
functional groups have been identified in Intimin: the highly conserved N terminus 
that inserts into the bacteria outer membrane and the C terminus that binds to 
translocated intimin receptor (Tir), integrin and nucleolin. Based on sequence and 
antigenic variation, at least 17 intimin types (α1, α2, β1, β2, γ1, γ2/ , δ/κ, ε, ζ, η, η2, 
ι, λ, μ, ν, ξ, o) have been identified. The main difference between various intimin 




and eae genes are most associated with severe human illness. However, many STEC 
strains without eae have also been isolated from patients with severe disease.    
Hemolysin 
Hly is one member of  the pore forming repeats in toxin (RTX) family toxins 
and that lyse erythrocytes, which can provide iron for bacteria from hemoglobin (2). 
Hly is encoded by four open reading frames (hlyCADB) and secreted into the 
extracellular space using a type I secretion system. Besides erythrocytes, Hly can 
cause membrane damage to a wide variety of other cell types and also may induce 
proinflammatory cytokine production (1). Hly presents in both eae-positive and eae-
negative STEC. However, a Finish study showed that hlyA was positive in 92% of 
eae-positive strains, but only 35% in eae-negative strains (31).  
 
Pathogenicity islands in STEC 
Increasing evidence has shown that the main difference between pathogenic 
strains and non-pathogenic strains of the same or closely related species are virulence 
genes encoded on large, horizontally acquired "gene cassettes" referred to as 
pathogenicity islands (PAIs) (6).  PAIs are genome regions that contain large blocks 
of virulence genes (32).  There are several features shared by all pathogenicity 
islands. The size of PAIs is usually larger than 10 kb. The G+C content and codon 
usage of PAIs are usually different from the core genome. A t-RNA gene is often 
present in one side of PAIs. In addition, PAIs are often flanked by direct repeat 
sequences and its genome commonly contains mobile genetic elements, such as 




virulence genes such as adhesion genes, type III secretion system (TTSS), invasion 
genes, enterotoxin, or siderphores. 
 In STEC, the locus of enterocyte effacement (LEE) is required for formation 
of attaching and effacing lesions and is the most characterized PAI (33). In EDL 933 
O157:H7, LEE is 43 kb and carries five functional polycistronic gene clusters (LEE1-
LEE5) consisting of 41 open reading frames. The five LEE functional modules 
include a type three secretion system; Intimin and its receptor; the secreted effectors 
EspF, EspG, EspZ, EspH, and CesT; the secreted translocators (EspA, EspD and 
EspB) that are required to inject effectors into host; and regulators such as Ler (LEE-
encoded regulator), GrlA (global regulator of LEE) and GrlR (global regulator of 
LEE-repressor) (32). 
Besides LEE, OI-O122 is another PAI that is well described (6, 34). In 
O157:H7, OI-122 is a 23 kb island. Several virulence genes have been identified in 
this island. Efa1 (EHEC factor for adherence) is an adhesin originally described in 
some EHEC strains (35). The efa1 gene is almost identical to lifA, an EPEC gene 
encoding lymphostatin (LifA), which can inhibit the proliferation of mitogen-
activated lymphocytes and the synthesis of proinflammatory cytokines (36). In 
addition, Efa1/LifA contributes to EPEC adherence to epithelial cells and is critical 
for intestinal colonization by Citrobacter rodentium, which is an AE lesion-producing 
bacterial pathogen of mice (37). PAI OI-122 also harbors genes that are very similar 
to pagC of Salmonella enterica serovar Typhimurium, sen of Shigella flexneri, and 
two C. rodentium non-LEE encoded effector genes (nleB and nleE). PagC is required 




encodes an S. flexneri enterotoxin (6). NleB is linked to colonization and disease in 
mice (38). NleE induces polymorphonuclear (PMN) transepithelial migration and is 
involved in the blockage of NF- κB activation (39, 40). 
OI-43 and OI-48 are duplicate genomic islands found in the EDL933 genome 
(41). OI-43/48 genes can be divided into three function groups. The first group is a 
gene cluster of seven genes (ureDABCEFG) related to urea resistance. The inactive 
aproprotein (Ure ABC) is activated by the addition of two Ni
2+
 ions to each of the 
three active sites in the enzyme. Accessory genes, Ure D, UreE, UreF and UreG, are 
all needed for the function of urease (42). The second group is a gene cluster for 
tellurite resistance. Ter
r
 in EHEC strain EDL933 is encoded by terZABCDEF (43). 
The third group includes putative adhesion genes iha (iron-regulated gene A) and 
aidA-1 (Adhesin involved in diffuse adherence) (42). 
OI-57 is another genomic island associated with virulence (44, 45). Three 
non-LEE secreted effectors (NleG2-3, NleG6-2 and NleG 5-2) are located in this 
island.  Although the biological function of those three genes is not clear yet, similar 
proteins as NleG are related that act to compromise the immune response of the host. 
The high pathogenicity island (HPI), which encodes for a siderophore 
(yersiniabactin) mediating iron-uptake system, was first detected in Yersinia pestis 
(46).  HPI is required for full virulence expression in Yersinia. Interestingly, an 
orthologous and highly conserved HPI is widely distributed among different species 
and genera of the family Enterobacteriaceae. FyuA is an outer membrane protein 
acting as a receptor for ferric-yersiniabactin uptake and for the bacteriocin pesticin 




Reservoirs and transmission  
 
STEC strains have been isolated from a variety of hosts such as pigs, sheep, 
goats, cats, deer, hogs, dogs, flies and birds (5). Ruminants, especially cattle, are 
recognized as the major reservoirs for STEC O157 and apparently also for the 
reservoirs of non-O157 STEC.  In the United States, cattle are considered the major 
reservoirs for STEC. However, in Australia, sheep are the major carriers of STEC (1).  
There are more than 435 serotypes of STEC that have been isolated from cattle (1, 
48).  A German study found a high association with the population of cattle and the 
number of non-O157 infection cases (49). A large number of the serotypes isolated 
from animals has also been isolated from patients.  
Cattle transit STEC to humans mainly through fecal shedding. Some cattle are 
“super shedders.” Although they account for only a small portion of the whole cattle 
community, “super shedders” are responsible for over 95% of STEC shed (50). 
Intimate attachment of STEC in the recto-anal conjunction (RAJ) contributes to the 
high concentration of STEC in the feces and prolonged shedding (51).  
STEC from cattle manure can be transferred to humans through contaminated 
meat, milk, and dairy products.  Drinking water or lakes may also be contaminated by 
fecal materials. In addition, fruits and vegetables can be contaminated by irrigation 
water or directly by fertilized manure. Furthermore, non-O157 can be transmitted to 






Contamination in meat  
 
Non-O157 STEC has been isolated from a variety of foods such as raw milk, 
beef, minced meat, pork, cheese, sausage, ice cream and lettuce.  For meat products, 
Sekala et al. reported a prevalence of 5.45% in beef in Canada (52).  In France, Pradel 
reported that 3.9% of beef samples were contaminated with STEC (33).  However, 
STEC was found in 12% of ground beef in Spain (53), and in 16% of ground beef in 
Australia (54). For pork products, very few studies are available for the contamination 
rates. Samapour et al. reported that 9 of 51 pork samples were positive for stx probe, 
but only one isolate was recovered (55). In Austria, Mayrhofer et al. reported 1.7% 
pork samples were positive for STEC in (56). In a recent study in Korea, only 2.0% 
of pork samples were positive for STEC (57).    
Isolation and detection challenge  
 
Sorbitol-MacConkey (SMAC) is the most widely used media to isolate O157 
and is based on the fact that most of O157:H7 cannot ferment sorbitol. SMAC is an 
effective media to differentiate O157:H7 and inhibit the growth of Gram-positive 
bacteria by crystal violet and bile salt. However, it is almost impossible to 
differentiate non-O157 in SMAC because all non-O157 colonies will be pink to 
mauve on this media.  
Currently, isolation of non-O157 STEC from food faces many challenges. 
Food samples usually contain a variety of high background flora and it is common 
that the target cells, non-O157 STEC cells, are present in low number (58). Food 
processing often injures the bacteria cells or transfers them into viable but 




involved and possible nonhomogeneous distribution of non-O157 STEC make 
recovery of them from food samples even harder (58). Enrichment of the food 
samples is often required to overcome these challenges. Enrichment can recover the 
injured and VBNC cells, dilute the effect of food matrix inhibitors, and increase the 
number of target cells by millions of times (58). Besides the common challenges 
facing isolation of all targets cells, there are some unique challenges for isolation of 
non-O157 STEC. STEC comprises over 400 serotypes and they differ greatly in their 
pathogenic potential and physical characteristics (11). There is no single biochemical 
characteristic that can distinguish non-O157 STEC from generic E. coli.  
The most common media used for enriching non-O157 STEC are Trypticase 
Soy Broth (TSB), Buffered Peptone Water (BPW), and E. coli broth (EC). In order to 
inhibit the growth of Gram positive or other background flora, many researchers add 
bile salts and novobiocin to the base media (59).  However, research has 
demonstrated that novobiocin can inhibit the growth of non-O157 and it is not 
recommended to add it to the media. Other antibiotics such as cefixime, vancomycin 
and selective agents (tellurite) are also used to inhibit background flora; however, 
some of non-O157 are sensitive to one or more of  these agents and adding antibiotics 
to the media may affect recovery rate for non-O157 STEC from food (59).  In 
addition to the enrichment media, the incubation temperature is very critical in 
recovering STEC from food samples. Several studies have found that enrichment at 
42 
o
C is more effective for isolating non-O157 STEC than at 37 
o
C from food 
products such as ground beef, cheese, apple juice and radish sprouts (60-63). Baylis 








factor contributing to the growth of 20 STEC strains in pure culture (59). However, 
enrichment at 42
 o
C can effectively inhibit the growth of background flora (59).  
Recently, an acid treatment procedure was reported that can effectively reduce the 
background flora in fecal samples and enhance the recovery of non-O157 STEC (64).  
The newly released USDA non-O157 isolation protocol uses 42
 o
C incubation 
temperature and exposure to acid treatment to increase the STEC recovery rate (65). 
PCR or real-time PCR (singular or multiplex) targeting stx genes post 
enrichment acts as an effective, rapid and very specific screening tool.  However, the 
drawback of this method is that it may cause false positives because some other 
bacteria species such as Shigella dysenteriae also contains one or more stx genes. Not 
only other bacteria, but also free phage containing stx phage can cause a false 
positive.  Enzyme immunoassay (EIA) targeting Stx is another method to detect the 
existence of non-O157 STEC.  The advantage of this method is that it targets all 
strains of STEC and it is often used as “golden standard” to detect STEC infection. 
However, false positives can also be observed when other bacteria or free phage are 
present. 
Due to the importance of O26, O45, O91, O103, O111, O113, O121, and 
O145 STEC, numerous methods targeting genes or antigens of lipopolysaccharide 
have been developed. These methods include PCR, real-time PCR, Luminex array, 
immunomagnetic separation (IMS), loop-mediated isothermal amplification and so 
on. Although these methods can rapidly detect specific E. coli serotypes. However, 
the E. coli serogroups detected by these methods are not necessarily STEC because 






As emerging pathogens, non-O157 can cause both life-threatening diseases 
and huge foodborne outbreaks.  Some non-O157 STEC are considered as virulent as 
O157 STEC. The public health concern of non-O157 is continuously increasing. Most 
of the STEC research focuses on O157; non-O157 STEC are not well characterized as 
foodborne pathogens and there is an urgent need to differentiate pathogenic and non-
pathogenic STEC. The objective of this study was to explore non-O157 STEC of its 
presence in food, pathogenicity islands, and molecular evolution. Three specific 
objectives were as follows:  
1) To identify the presence and characterization of non-O157 STEC from retail 
meats.  Meat, especially ground meat, is easily contaminated by STEC during 
processing. Thus, meat can serve as transmission vehicles for STEC. Although a lot 
of studies have been done on O157 in meat products, there is a paucity of data about 
non-O157 STEC contamination in meat in the United States. Thus, the first objective 
of this study is to determine the prevalence of non-O157 STEC from retail meat and 
explore its potential as a human pathogen. 
2) To determine distribution of pathogenicity islands and its associated virulence 
genes in non-O157 STEC.  Although more than 470 non-O157 serotypes have been 
isolated from humans, not all non-O157 STEC are created equal. The scientific base 
for this is not well understood. Pathogenicity island (PAI), which is normally highly 
prevalent in high pathogenic strains, but almost absent in non-pathogenic strains of 
the same or closely related species, may contribute to the virulence difference and be 
used as a marker to distinguish non-O157 STEC, causing severe disease with 
nonpathogenic or low pathogenic strains. Thus, it is important to determine the 





3) To determine the phylogenetic relationship of non-O157 STEC  
O157:H7 is proposed to be evolved from EPEC O55:H7. However, the evolutional 
relationship of non-O157 STEC has not been well unveiled. Among all non-O157 
STEC, serogroups O26, O111 and O103 caused most of the known outbreaks and 
severe diseases. Identifying its phylogenetic evolution can provide us with a model to 
study the evolution of non-O157 STEC and to help understand the pathogenesis 
evolution of non-O157 STEC. Determination of non-O157 phylogenetic relationship 
can also help to set bases for new markers.  
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CHAPTER II: NON-O157 SHIGA TOXIN-PRODUCING 
ESCHERICHIA COLI IN RETAIL GROUND BEEF AND 
PORK IN THEWASHINGTON D.C. AREA 
 
Abstract 
The prevalence and characteristics of non-O157 Shiga toxin-producing 
Escherichia coli (STEC) in retail ground meat from the Washington D.C. area were 
investigated in this study. STEC from 480 ground beef and pork samples were 
identified using PCR screening followed by colony hybridization. The STEC isolates 
were serogrouped and examined for the presence of virulence genes (stx1, stx2, eae 
and hlyA), and antimicrobial susceptibility.  PFGE was used to identify the clonal 
relationships of STEC isolates, and PCR-RFLP was employed to determine stx 
subtypes. In addition, the cytotoxicity of STEC isolates was determined using a Vero 
cell assay. STEC were identified in 12 (5.2%) of 231 ground pork and 13 (5.2%) of 
249 ground beef samples.  Among 32 STEC isolates recovered from the 25 samples, 
12 (37.5%) carried stx2dact and 7 (21.9%) carried hlyA, but none carried eae. Nine 
isolates were identified as O91, and 17 (53.1%) isolates were resistant to two or more 
antimicrobials. Verotoxicity was detected in 26 (81.3%) of the STEC isolates. Thus, 
the retail ground meat was contaminated with a heterogeneous population of non-







Shiga toxin-producing  Escherichia coli  (STEC) are important foodborne 
pathogens worldwide (1).  Most STEC infections cause self-limiting diarrhea, but 
some can progress to life-threatening diseases such as hemolytic uremic syndrome 
(HUS). To date, more than 470 STEC serotypes have been reported to be associated 
with human illness (2).  E. coli O157: H7 is the predominant serotype associated with 
outbreaks and sporadic cases of STEC infections in the United States (3). However, a 
growing number of non-O157 serotypes have also been linked to human illnesses, 
including HUS (4).  In the United States, non-O157 STEC cause an estimated 
112,752 cases of illness each year, whereas E. coli O157:H7 causes 63,153 cases per 
year (5). Depending on geographic location, a variety of non-O157 serotypes were 
isolated from patients with STEC infections (6, 7). As only a limited number of 
laboratories test for non-O157 STEC, the public health risk associated with non-O157 
STEC is likely underestimated. 
Shiga toxin-producing E. coli are defined by their production of one or more 
Shiga toxins (Stx). The Stx family consists of two groups: Stx1 and Stx2. Stx1 is 
highly homogenous and consists of Stx1a, Stx1c and Stx1d (8, 9), whereas, Stx2 
contains several variants including Stx2a, Stx2c, Stx2d, Stx2dact, Stx2e, Stx2f and 
Stx2g (10). Certain Shiga toxin subtypes are highly associated with clinical 
syndromes (11). STEC strains carrying certain stx2 genes were frequently associated 
with severe diseases such as hemorrhagic colitis (HC) and HUS (12).  Additionally, 
Intimin, an outer membrane protein encoded by eae that resides in the locus of 




However, STEC strains lacking eae have also been isolated from patients with severe 
disease (14).  Additional adhesion factors, such as Saa (STEC autoagglutinating 
adhesion), Iha (IrgA homologues adhesion), and LPF (long polar fimbriae), may 
contribute to the adhesion process of eae-negative STEC (15). 
Shiga toxin-producing E. coli are transmitted to humans mainly through 
consumption of contaminated food and water (16). Ground meat presents a greater 
risk than intact muscle because it can be contaminated with STEC during processing, 
and the pathogens present inside the ground product are more likely to survive during 
cooking (17).  However, limited information is available about non-O157 STEC 
contamination in retail ground meat in the United States.  The objectives of this study 
were to determine the prevalence of non-O157 STEC in ground meat in the 






Materials and Methods 
Sampling, culture enrichment and PCR assay. From March 2009 to March 
2010, 480 samples (249 ground beef and 231ground pork) were collected weekly 
from three grocery chain stores in the Washington D.C. area, USA. The USDA-FSIS 
enrichment method was used in this study with modification (18). Briefly, a 25 g 
portion of each sample was placed in a plastic filter bag with 225 ml of modified 
tryptic soy broth (mTSB; 30 g TSB base, 1.5 g bile salts No. 3  and 1.5 g dipotassium 
phosphate per liter of distilled water) (Becton Dickinson, Sparks, MD).  After  
homogenizing in a stomacher (Seward, Bohemia, NY), each sample was incubated 
for 15 to 22 h at 42 °C in a water bath with shaking at 100 rpm.  One milliliter of the 
broth culture was taken for DNA extraction using the InstaGene DNA extraction kit 
(Bio-Rad, Hercules, CA) according to the manufacturer’s instructions.  A PCR assay 
described by Lin et al was used to identify stx-positive samples (19). It amplified 
stx1a, stx1c, stx1d, stx2a, stx2c, stx2d, stx2dactive, stx2e, stx2f (19-22). The PCR was 
performed in a 25 µl reaction mixture containing 3µl of DNA template, 2.5 µl of 10 x 
PCR buffer, 2 µl of 25 mmol l
-1
 MgCl2, 2 µl 1.25 mmol l
-1
 dNTP mix, 0.125 µl of 5 U 
µl
-1
 AmpliTaq Gold DNA polymerase mix (Applied Biosystems, Branchburg, NJ)  
and 0.2 µl of  50 pmol µl
 -1
 of each primer. Thermal cycle condition was used as 
previously described (19).  E. coli O157:H7 EDL933 and E. coli K-12 were used as 
positive and negative controls, respectively, in all PCR assays.  
 
Colony hybridization. A colony hybridization procedure targeting stx genes 




both stx1 and stx2 was prepared by labeling stx-PCR amplicons from E. coli EDL 933 
using the PCR DIG probe synthesis kit (Roche Applied Science, Indianapolis, IN) 
according to the manufacturer’s instructions. In order to isolate STEC, up to six 
hybridization positive colonies were randomly picked and grown at 37 °C overnight 
on LB agar (Becton Dickinson, Sparks, MD). Isolates were determined as E. coli 
using the Vitek 2.0 system (bioMerieux, Marcyl’Etoile, France).  
 
Molecular characterization of virulence genes. Two multiplex PCRs were 
used to determine the presence of stx1, stx2, eaeA and hlyA in STEC isolates (15). 
PCRs were performed in a 25 µl reaction system with 0.2 µl of 50 pmol µl
 -1
 of each 
primer. stx subtypes were determined using PCR-RFLP as described previously (23) 
with the following control strains: EDL933 (stx1a and stx2a), E32511 (stx2c), EH250 
(stx2d),  S1191 (stx2e), B2F1 (stx2dactive) and N15018 (stx1c). stx2dact was 
confirmed by PCR  according to our previously reported method (25).  
Pulsed-field gel electrophoresis (PFGE). PFGE was performed following 
the updated protocol for non-O157 from PulseNet (24). Salmonella Braenderup 
H9812 was used as control for PFGE. PFGE gel pictures were analyzed with 
Bionumerics Software (Applied Maths, Austin, TX) using dice coefficients and 






 Vero cell cytotoxicity assay. Shiga toxin production of STEC isolates was 
evaluated using a Vero cell cytotoxicity assay as previously described (15, 25). 
Briefly, Vero cells were grown in Eagle's Minimum Essential Medium (EMEM) 
(ATCC, Manassas, VA) supplemented with 10% fecal calf serum (Phenix Research 
Product, Candler, NC) under 5% CO2 at 37°C.  STEC isolates were inoculated in LB 
broth (Becton Dickinson, Sparks, MD) and incubated at 37°C overnight with shaking 
at 100 rpm. After adjusting the cell concentration to 10
9
 CFU/ml with LB broth, 2 ml 
of the culture was centrifuged at 10,000 rpm for 10 min, and the supernatant was 
filtered through a 0.45μm–pore-size membrane filter (Fisher HealthCare, Houston, 
TX). The filtrate was serially diluted (1:5) and 100μl of each dilution was added to 
each well that was preseeded with Vera cells. After incubation under 5% CO2 at 37°C 
for 48 h, 200 µl of 2% formalin in 0.067 M phosphate-buffered saline (pH 7.2) was 
added to fix Vero cells. After 1 h, the fixed cells were stained with 0.13% crystal 
violet in 5% ethanol for 30 min.  The color density of each well was measured using a 
Elx800 microplate reader (Bio-Tek Instruments, Winooski, VT) at 600 nm. EDL933 
and E. coli k-12 were used as positive and negative controls, respectively. All assays 
were conducted in triplicate and repeated independently three times. 
 
 Molecular serogrouping. Serogroups including O8, O26, O28, O45, O91, 
O103, O111, O121, O145, and O157 were screened using PCR assays with primers 
based on the wzy gene (Table II-1). Each PCR was performed in a 25 µl reaction 
mixture containing 2 µl of DNA template, 2.5 µl of 10 x PCR buffer, 2 µl of 25 mmol 
l
-1
 MgCl2, 2 µl of 1.25  mmol l
-1
 dNTP mix, 0.125 µl of 5 U µl
-1




DNA polymerase mix (Applied Biosystems)  and 0.2 µl of 25 pmol µl
-1 
of each 
primer. An annealing temperature of 55 °C was used for all PCRs. The following 
strains were used as positive controls: EDL933 (O157:H7), UMD141 (O26:H11), 
UMD144 (O45:H2), TW7990 (O103:NM), UMD168 (O111:NM), SJ19 (O121:H19), 
UMD248 (O8:H4), P1334 (O91:H21),  UMD327 (O28:NM), and SJ23 (O145:NM). 
E.coli K12 was used as negative control for all PCR assays. 
 
 Antimicrobial susceptibility. The antimicrobial susceptibilities of the STEC 
isolates were determined using a broth microdilition method (Sensititre system; Trek 
Diagnostic systems, Westlake, OH)  and interpreted according to Clinical and 
Laboratory Standards Institute (26). The following antimicrobials were used: 
tetracycline, streptomycin, sulfisoxazole, nalidixic acid, kanamycin, amikacin, 
amoxicillin/clavulanic acid, ampicillin, cefoxitin, ceftiofur, ceftriaxone, 
chloramphenicol, ciprofloxacin, gentamicin, and trimethoprim/sulfamethoxazole. 
Quality control organisms were E. coli ATCC 25922, Staphylococcus aureus ATCC 
29213, Pseudomonas aeruginosa ATCC 27853, and Enterococcus faecalis ATCC 
29212.  
Data analysis. Chi square or Fisher's exact tests and T-test were used to 
analysis the data using SAS9.2 (SAS Institute, Cary, NC). A p-value of < 0.05 was 







 Prevalence of STEC in ground beef and pork. Among the 249 ground beef 
and 231 ground pork samples, 21 (8.5%) beef and 31 (13.4%) pork samples were 
positive for stx gene(s) by the PCR screening. Positive broth samples were further 
analyzed for STEC using colony hybridization.  Overall, STEC were isolated from 13 
(5.2%) of the beef and 12 (5.2%) of the pork samples. There was no significant 
difference in the prevalence of stx genes and STEC between pork and beef samples. 
Multiple STEC isolates were recovered from several samples resulting in a total of 32 
isolates (16 from beef and 16 from pork).    
 
 Molecular characteristic of STEC isolates. PCR assays revealed that 10 
(31.3%) of the 32 STEC isolates contained stx1, whereas 22 (68.7%) carried stx2 but 
none harbored both stx1 and stx2 (Figure II-1). stx1 was significantly more prevalent 
in STEC isolates from pork (50.0%) than in isolates from beef (12.5%)  (P< 0.05); 
and stx2 was significantly more prevalent in STEC isolates from beef (87.5%) than in 
isolates from pork (47.1%) (P< 0.05). Of 10 STEC isolates carrying stx1, 9 were 
positive for stx1a and 1 for stx1d.  Among 22 stx2-carrying STEC isolates, 8 were 
positive for stx2a, 3 for stx2a and stx2dact, 9 for stx2dact, and 2 for stx2e. None of 
the STEC isolates contained the eae gene, but seven isolates (21.9%) harbored hlyA. 
There was no significant difference in the carriage of hlyA between STEC recovered 
from ground beef (31.3%) and STEC from ground pork (17.6%). Of the seven hlyA-




as serogroup O91, including eight from pork and one from beef (Figure II-1). The 
others did not belong to any of the other serogroups examined. 
 
Pulsed-field gel electrophoresis (PFGE). A total of 26 distinct PFGE 
profiles were identified among the 32 STEC isolates, indicating heterogeneous STEC 
were present in the retail meat (Figure II-1). There was more than one PFGE pattern 
among STEC isolated from six samples (2, 158,197, 347, 348 and 380), suggesting 
that these samples were contaminated with multiple STEC clones. Additionally, 
identical PFGE profiles were found among STEC recovered from pork and beef 
samples (195-1, 196-6, 197-1 and 199-4; 126-1 and 419-1). Identical PFGE patterns 
were also obtained with different samples from the same source (347-2 and 348-1) 
(Figure II-1).  
 
Vero cell cytotoxicity. Among the 32 isolates, 26 demonstrated toxicity to 
Vero cells, whereas 6 (3 from beef and 3 from pork) had no detectable cytotoxicity 
effect when compared with the negative control (Figure II-2).  Three isolates (126-1, 
245-1 and 460-10) displayed high cytotoxicity similar to that of the positive control 
strain E. coli O157:H7 EDL 933. All O91 isolates except 119-2 showed high 
cytotoxic effect to Vero cells. No significant difference in cytotoxicity between beef 
and pork STEC isolates was observed. 
 
Antimicrobial susceptibility. Eighteen of the 32 STEC isolates (56.3%) were 




tetracycline, 14 (43.8%) to streptomycin, 13 (40.6%) to sulfisoxazole, 4 (12.5%) to 
nalidixic acid and 3 (9.4%) to kanamycin (Table II-2).  Significantly more pork 
isolates (75.0%) than beef isolates (37.5%) were resistant to one or more 
antimicrobials (P< 0.05). Among the pork isolates, 12 (75.0%) were resistant to 
tetracycline, 8 (50.0%) to sulfisoxazole, 10 (62.5%) to streptomycin, 2 (12.5%) to 
nalidixic acid and 3 (18.8%) to kanamycin.  Of the beef STEC isolates, 5 (31.2%) 
were resistant to tetracycline, 5 (31.2%) to sulfisoxazole, 3 (18.8%) to streptomycin, 
and 2 (12.5%) to nalidixic acid. Resistance to streptomycin and tetracycline was 
significantly more common in pork than in beef isolates (P< 0.05). All isolates were 
susceptible to amikacin, amoxicillin/clavulanic acid, ampicillin, cefoxitin, ceftiofur, 








Isolation of non-O157 STEC from meat products containing a large number of 
other bacteria is still a challenge, since non-O157 STEC strains show great genetic 
and biochemical diversity, and there is no unique phenotypic marker that can 
differentiate them from other E. coli.  There was no standard method to detect non-
O157 STEC in meat product at the time the study was conducted. An enrichment 
protocol used originally for detecting O157:H7 in meat products by USDA-FSIS was 
adapted to detect STEC in ground beef and pork (18).  As we used the same meat 
samples for testing other pathogens, 25 g instead of 325 g of sample was taken for the 
culture enrichment and isolation of STEC.  In order to support the growth of all 
STEC, novobiocin was not added as studies showed that nonvobiocin inhibits the 
growth of some non-O157 STEC (27, 28).  Instead, bile salt No. 3 was added to 
inhibit Gram-positive bacteria, and a higher temperature (42 °C) was used to control 
the growth of other Enterobacteriaceae (29). Shaking at 100 rpm was also employed 
to enhance the growth of non-O157 STEC, especially those that might be injured 
during meat processing. However, a study showed that shaking could inhibit the 
detection of O157:H7 (30).  The above variations may have contributed to a possible 
lower recovery rate of non-O157 STEC in our study.   
Colony hybridization was employed to increase isolation rates of STEC as it 
allows the simultaneously screening of 100-200 colonies. Overall, 21 (8.5%) beef and 
31 (13.4%) pork samples were positive for stx gene, and STEC isolates were 
recovered from 13 (5.2%) and 12 (5.2%) beef and pork samples, respectively.  Failure 




possible reasons like low numbers of STEC in the meat sample, high levels of 
background bacteria, the presence of stx carrying phages, the loss of stx during 
subculture of the bacteria, or the presence of other bacteria carrying stx (1, 31).  
Contamination of STEC in ground beef has been studied by researchers 
around the world and it has been shown that the prevalence of non-O157 STEC 
ranges from 2.4% to 30% (32). A recent study of non-O157 STEC in the United 
States showed that 7.3%  ground beef samples were positive for non-O157 STEC 
(33). Sekala et al. reported  a prevalence of 5.5% STEC  from 165 ground beef 
samples in Canada, in which 3.03% (5/165) were non-O157 STEC (34).  In France, 
3.9% of 411 beef samples were contaminated by non-O157 STEC (35). A much 
higher prevalence of non-O157 STEC was reported in ground beef samples in France 
(11%) (36) and Australia (16%) (17).  The present study had a positive rate of 5.2% 
after testing 249 ground beef samples, and was in agreement with some of these 
reports.  However, it is very difficult to compare different studies as geographical 
location, sampling, isolation and detection methods can affect the prevalence data 
significantly.  
Compared to beef, fewer reports on the contamination of STEC in pork are 
available.  In the present study, 12 (5.2%) pork samples were positive for non-O157 
STEC, which was similar to the prevalence of non-O157 STEC in ground beef.  We 
also identified 8 out of 16 STEC isolates from pork were O91, which has been 
associated with diarrhea and HUS (37). Read et al reported that 3.8% (9/235) ground 
pork samples were positive for non-O157 STEC in Canada (38), whereas only one 




120 pork samples were positive of STEC (40). More recently, 2.0% of 201 pork 
samples were found positive for STEC in Korea (41). These studies indicated that 
pork may also be a vehicle for transmission of STEC to humans.   
Shiga toxin subtypes have been highly associated with clinical syndromes. 
Stx2a and Stx2dact are linked with high virulence and ability to cause severe disease. 
In this study, 9 out of 32 STEC isolates from retail meat harbored stx2dact, 3 with 
both stx2a and stx2dact. Although these STEC did not carry eae, they could still 
cause severe disease and outbreaks (42, 43). Only limited data on the presence of 
stx2dact-positive STEC in food are available. We previously reported that 5 of 16 
STEC recovered from retail ground beef harbored stx2dact (15), and that 7 out of 153 
STEC from food, cattle and human carried stx2dact, of which 2 were from food (25).  
In addition, Gobius et al found that 4 of 63 STEC isolates from ground beef and 1 of 
103 from lamb meat contained stx2dact (44). These findings indicated that stx2dact-
positive STEC are not uncommon in meat products.  
While most STEC in the present study showed Vero cytotoxicity, six isolates 
were not cytotoxic to Vero cells.  One possible explanation could be that the 
expression of stx was at very low level in those isolates.  Previous studies found that 
some STEC strains produced low levels of Stx that could not be detected using tissue 
culture (45). It is also possible that although some STEC carry intact stx, it is not 
expressed (45).  Lack of stx expression has been reported in stx2g STEC (23, 46, 47). 
Additionally, it is possible that those stx genes were not phage born or were from 




STEC particularly E. coli O157:H7 often carry other virulence genes in 
addition to stx (s), including eae and hlyA. Although eae is considered essential for 
causing attaching and effacing lesions in human intestinal epithelial cells, it may not 
be necessary for STEC pathogenicity.  STEC lacking eae have been reported to cause 
illnesses including life threatening HUS and foodborne outbreaks (48, 49). None of 
the 32 STEC isolates in the present study carried eae, but nine belonged to O91, a 
STEC serogroup associated with clinical cases (37, 50). O91 is one of the most 
common serogroups isolated from adult patients (37). Additionally, the O91 STEC 
isolates except 119-2 demonstrated high cytotoxicity for Vero cells, indicating the 
potential as human pathogens.  
While most E. coli O157:H7 are susceptible to antimicrobials, many non-
O157 STEC isolated from humans and animals have shown resistance to multiple 
antimicrobials (51). More than half of the STEC isolates in the current study were 
resistant to two or more antimicrobials. Tetracycline, sulfisoxazole and streptomycin 
were the most common antimicrobials to which STEC were resistance to, similar to 
the findings of other studies (52-54). A greater resistance level was found in STEC 
from ground pork (12/16) than from ground beef (6/16).  This is likely due to 
differences in animal husbandry practices in the raising of hogs and cattle for meat. 
 
This study showed that ground beef and pork can be contaminated with 
heterogeneous STEC, many of which were resistant to commonly used 
antimicrobials. Some STEC belonged to serogroup associated with human illness and 




humans. Education of consumers and food handlers on STEC in food are needed to 
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                             Primer Size  Accession Number 
 
O8 5'-ACACCACAAACGATAATCAATGCC-3' 272 
 
AF013583.1 
 5'-GACCGATTAACAGCCAACACAGGT-3'   
O26 5'-TAATTGGCTTGCTGGGTTTATTCC-3' 422 AF529080.1 
 5'-AGAATGAACCTTAATGCCATCAGC-3'   























































TABLE II-2.  Antimicrobial resistance profiles of non-O157 STEC recovered 






No. (%) Isolates 
 from beef 
No. (%) isolates  
from pork 
NAL-STR-FIS-TET 1 (6.25%) 2 (12.50%) 
KAN-STR-FIS-TET 0 (0.00%) 1 (6.25%) 
NAL-FIS-TET 1 (6.25%) 0 (0.00%) 
KAN-FIS-TET 0 (0.00%) 1 (6.25%) 
KAN-STR-TET 0 (0.00%) 1 (6.25%) 
STR-FIS-TET 1 (6.25%) 3 (18.75%) 
STR-TET 1 (6.25%) 2 (12.50%) 
FIS-TET 2 (12.50%) 1 (6.25%) 
FIS 0 (0.00%) 1 (6.25%) 
Total 6 (37.50%) 12 (75.00%) 
a















FIGII-1. Dendrogram of PFGE profiles with XbaI of 32 STEC isolates from ground beef and pork.  
Similarity of the PFGE profiles was based on the Dice algorithm with 1.5% tolerance.  (UN: unidentified by PCR for E. coli 





Isolates No.       Source      Serogroup*       stx subtype hlyA










































































































































































FIG II-2. Vero cell cytotoxicity of 32 STEC isolates from ground beef and pork.  
(CD50 = toxin dilution needed to cause 50% of cell detachment compared with untreated cell.  CD50 value for each strain was an 
average of three independent assays.  Values on the Y axis indicate the log of the reciprocal of CD50 values. E. coli O157:H7 EDL933 










CHAPTER III: DISTRIBUTION OF PATHOGENICITY 
ISLANDS OI-122, OI-43/48, OI-57 AND HIGH 
PATHOGENICITY ISLAND (HPI) IN SHIGA TOXIN-
PRODUCING ESCHERICHIA COLI  
 
Abstract 
Pathogenicity islands (PAIs) play an important role in STEC pathogenicity. 
The distribution of PAIs OI-122, OI-43/48, OI-57 and high pathogenicity island 
(HPI) were determined among 98 STEC strains assigned to seropathotypes (SPT) A 
to E. PCR and PCR-RFLP assays were used to identify 14 virulence genes that 
belonged to the four PAIs, and to subtype eae and stx genes, respectively. 
Phylogenetic trees were constructed based on the sequences of pagC among 34 STEC 
strains and iha among 67 diverse pathogenic E. coli, respectively. Statistical analysis 
demonstrated that the prevalence of OI-122 (55.82%) and OI-57 (82.35%) was 
significantly greater in seropathotypes (SPT A, B and C) that are frequently 
associated with severe disease than in other seropathotypes.  terC (62.5%) and ureC 
(62.5%) in OI-43/48 were also significantly more prevalent in SPT A, B and C than 
in SPT D and E. Additionally, OI-122, OI-57, OI-43/48 and their associated virulence 
genes (except iha) were found to be primarily associated with eae-positive STEC, 
whereas HPI occurred independently of the eae presence. The strong association of 
OI-122, OI-43/48 and OI-57 with eae-positive STEC suggests in part different 
pathogenic mechanisms exist between eae-positive and eae-negative STEC. 
Virulence genes in PAIs that are associated with severe diseases can be used as 





Shiga toxin-producing Escherichia coli can cause human illnesses ranging 
from self-limiting diarrhea to life-threatening diseases such as hemolytic uremic 
syndrome (HUS), a leading cause of kidney failure in children (1). E. coli O157:H7 is 
the single serotype that causes most STEC outbreaks and HUS cases. Like O157, 
non-O157 STEC can also cause severe diseases and foodborne outbreaks (1). There 
are more than 470 non-O157 STEC serotypes have been associated with human 
illness (2) and the public health concerns of non-O157 STEC is increasing (1). 
Estimations indicate that non-O157 STEC cause 112,752 illness each year in the 
United States, almost doubling the numbers of O157:H7 illnesses (63,153)  (3). While 
some non-O157 STEC have been associated with disease symptoms indistinguishable 
from O157:H7, not all STEC can cause HUS and outbreaks, and some STEC 
serotypes have never been reported related to any human illness (4). The scientific 
basis for this difference, however, is poorly understood.  
Increasing evidence shows that differences in virulence between pathogenic 
and nonpathogenic bacterial strains can be attributed in part to virulence genes 
located in pathogenicity islands (PAIs) (5). PAIs usually contain blocks of virulence 
genes and are greater than 10 Kb (6). Several PAIs have been identified and 
characterized in STEC. A chromosomal pathogenicity island termed the locus of 
enterocyte effacement (LEE) was identified in E. coli O157:H7 strain EDL933, which 
encodes a type III secretion system (TTSS) as well as virulence genes (eae and tir) 
associated with the intimate attachment of bacteria to intestinal epithelial cells (4). 




commonly associated with HUS and outbreaks than LEE-negative STEC (5). 
However, some LEE-positive STEC serotypes have never been associated with 
disease, and some LEE-negative STEC can cause HUS and outbreaks, indicating that 
virulence factors other than those in LEE may contribute to pathogenesis of STEC 
(5). 
Pathogenicity island OI-122 is also well characterized in O157:H7 (5, 7). OI-
122 is a 23 kb PAI consisting of three modules (5, 8, 9). Z4321 is located in module 
one and encodes a protein sharing 46% similarity with the phoP-activated gene C 
(pagC) of Salmonella Typhimurium (5, 9). Z4326, Z4328, and Z4329 are located in 
module two. Z4326 (sen)  encodes a protein that shares 38.2% similarity to Shigella 
flexneri enterotoxin 2 (5), whereas Z4328 and Z4329  encode proteins that have  89% 
and 86% similarity to non-LEE encoded effectors NleB and NleE, respectively (9). 
The enterohemorrhagic E. coli factor for adherence (Efa), which is involved in 
epithelial cell adhesion and proliferating the inhibition of bovine peripheral blood 
lymphocytes, is located in module three (10). 
OI-43 and OI-48 are duplicate genomic islands found in EDL933 (8). OI-
43/48 genes are divided into three functional groups: a seven-gene cluster 
ureDABCEFG that encodes urease and accessory proteins hydrolyzing urea to 
ammonia and carbon dioxide; telluride resistance genes terZABCDEF (11); and two 
putative adhesion genes, iha (iron-regulated gene A) and aidA-1 (autotransporter 




In EDL933, OI-57 contains non-LEE encoded effector genes nleG2-3, nleG6-2, and 
nleG 5-2 (13, 14). NleG proteins are E3 ubiquitin ligases analogous to RING finger 
and U-box enzymes in eukaryotes. Although the exact functions of NleG2-3, NleG6-
2, and NleG 5-2 are still unclear, similar proteins have been identified as effectors 
that suppress immune response from the host (15).  
High pathogenicity island (HPI) was first detected in Yersinia pestis and other 
highly virulent Yersinia species, and encodes a siderophore (yersiniabactin) mediated 
iron-uptake system (16). HPI is required for full virulence expression in Yersinia (16), 
and contains two main virulence genes, fyuA and irp2. FyuA is an outer membrane 
protein acting as a receptor for ferric-yersiniabactin uptake and for bacteriocin 
pesticin, while Irp2 is involved in yersiniabactin synthesis (17).  An orthologous and 
highly conserved HPI is widely distributed among different species and genera of the 
family Enterobacteriaceae (16).  
Few studies have investigated PAIs other than LEE in STEC to date. Since 
PAIs are normally absent in non-pathogenic strains of the same or closely related 
species, they may serve as useful markers to distinguish highly virulent from less 
virulent or harmless strains (5, 6) . In addition, PAIs can be used to identify new and 
emerging pathogenic bacteria. In this study, we reported the distribution of OI-122, 
OI-43/48, OI-57, and HPI and their virulence genes in STEC, and evaluated the 
association of the PAIs and individual virulence genes with STEC seropathotypes 
linked to severe diseases and outbreaks. In addition, the association of the four PAIs 





Materials and Methods 
 Bacterial strains. A total of 98 STEC strains from humans, animals and food 
were used in this study (TABLE III-1). Strains were classified into seropathotypes A 
to E according to the criteria described by Karmali et al. (5). The assignment of 
seropathotypes was based on published references (5, 14, 18) and a large online 
database on non-O157 STEC (http://www.lugo.usc.es/ecoli/SEROTIPOSHUM.htm). 
stx and eae subtyping. stx and eae subtypes were determined using PCR-
RFLP analysis (19, 20), and stx2dact was confirmed by PCR as previously described 
(21). Genomic DNA was extracted using boiling method as previously described (22, 
23). STEC strains S1191 (stx2e), EDL933 (stx1a and stx2a), E32511 (stx2c), EH250 
(stx2b), B2F1 (stx2dact) and N15018 (stx1c) were used as positive controls for the stx 
subtyping; STEC strains 86-24 (gamma 1), EDL933 (gamma 1), TW06584 (kappa), 
E2348-69 (alpha), TW07920 (epsilon), RDEC-1 (beta), TW10366 (rho), TW03501 
(iota), TW07892 (eta), and TW01387 (gamma 2/theta) were used as positive controls 
for the eae subtyping.  E. coli K12 was used as a negative control strain for both stx 
and eae subtyping. 
Presence of OI-122, OI-43/48, O-57 and HPI. PCR assays were used to 
determine the presence of 14 virulence genes in STEC OI-122, OI-43/48, O-57 and 
HPI as described (5, 11, 13, 24, 25). The presence of a PAI was determined by 
several marker genes located in different regions of the island, including pagC, sen, 
nleB, efa-1, and efa-2 for OI-122; terC, ureC, iha and aidA-1 for OI-43/48; nle2-3, 
nleG6-2 and nleG5-2 for OI-57; and irp2 and fyuA for HPI. PCR was performed in a 




µl of 25 mmol l
-1
 MgCl2, 2 µl of 1.25 mmol l
-1
 dNTP mix, 0.125 µl of 5 U µl
-1
 
AmpliTaq Gold DNA polymerase mix (Applied Biosystems, Branchburg, NJ) and 0.2 
µl of 50 pmol µl
-1 
of each primer. E. coli O157:H7 EDL 933 was used as a positive 
control for the virulence genes of OI-122, OI-43/48 and OI-57, and E. coli O26:H11 
SJ-13 for virulence genes of HPI. E. coli K12 was used as a negative control for all 
PCR assays. 
Phylogenetic and sequences analysis. iha and pagC were the only two genes 
that were highly prevalent in both eae-positive and eae-negative STEC.  To 
determine the evolutionary relationship between the two groups of STEC, iha and 
pagC were selected for phylogenetic analysis studies. iha sequences from 67 E. coli 
and Shigella were obtained from the GenBank. A multiple sequence alignment of iha 
was performed using ClustalW in MEGA 5.05, and a maximum likelihood 
phylogenetic tree was generated using the General Time Reversible model (26). A 
bootstrapping of 2,000 replicates was used to estimate the confidence of the 
branching patterns of the phylogenetic tree using iha of E. coli SMS-3-5 as the 
phylogenetic tree’s root. 
Additionally, PCR was used to amplify pagC of OI-122 from 12 selected 
STEC strains representing different serotypes as described by Konczy et al (9). PCR 
products were sequenced by GeneWiz (Germantown, MD). Twenty two pagC 
sequences representing different STEC serotypes and one Citrobacter were 
downloaded from the GenBank. The pagC sequences were cropped to 446 bp prior 
alignment. Phylogenetic analysis was performed using ClustalW within MEGA 5.05 




likelihood methods by MEGA 5.05 with bootstrapping of 2,000 replicates using pagC 
of Citrobacter rodentium IC168 as the tree’s root.  
Statistical analysis. Chi square or Fisher's exact test was used for data 
analysis using SAS9.2 (SAS Institute, Cary, N.C.). A P-value of < 0.01 was 





Distribution of OI-122, OI-43/48, OI-57 and HPI in STEC. The 98 STEC 
strains were classified into seropathotypes A to E (TABLE III-1). Overall, the 
prevalence of OI-122 and OI-57 decreased progressively from seropathotype A (SPT 
A) to seropathotype E (SPT E) (FIG III-1). The prevalence of OI-122 and OI-57 was 
significantly higher in seropathotypes associated with severe diseases (SPT A, B, and 
C) and outbreaks (SPT A and B) than in other seropathotypes (P<0.0001) (TABLE 
III-2). Although the prevalence of OI-43/48 was greater in seropathotypes associated 
with HUS (SPT A, B and C) and outbreaks (SPT A and B) than in other 
seropathotypes, the difference was not statistically significant (P= 0.1356 and 0.02, 
respectively). HPI was not found in SPT A (O157), but was almost evenly distributed 
from SPT B to SPT E (FIG III-1). 
sen, nleB, efa-1, efa-2, terC, ureC, nleG2-1, nleG5-2 and nleG6-2 were 
significantly more prevalent in SPT A and B than in SPT C, D and E (TABLE III-3). 
pagC, sen, nleB, efa-1, efa-2, terC, ureC, nleG2-1, nleG5-2 and nleG6-2 were 
statistically more prevalent in SPT A, B and C than in SPT D and E (TABLE III-3). 
Although aidA-1 was more prevalent in SPT A and B than in SPT C, D and E, the 
difference was not statistically significant (P=0.27). iha, fyuA, and irp2 were less 
prevalent in SPT A, B and C than in SPT D and E, and the differences were not 
statistically significant neither. 
 
Distribution of OI-122, OI-43/48, OI-57 and HPI in EHEC O157. PAIs 




glucuronidase (GUD)-negative O157:H7, four strains all contained marker genes for 
OI-122, OI-57, and OI-43/48. In GUD-positive O157: H7, none of the five strains 
carried efa-1 and efa-2 (located at the third module of OI-122) or aidA-1(located at 
the end of OI-43/48). Sorbitol fermenting O157:NM strains contained all virulence 
genes of OI-122 and OI-57 but were negative for all the OI-43/48 virulence marker 
genes, indicating the absence of OI-43/48 in O157:NM. Additionally, none of the 
O157:H7 and O157:NM strains were positive of HPI virulence genes. 
 
Association of OI-122, OI-43/48, OI-57 and HPI with eae. We compared 
the distribution of virulence genes of OI-122, OI-43/48, OI-57, and HPI between eae-
positive and eae-negative STEC. All virulence genes of OI-122 and OI-57 (pagC, 
sen, nleB, efa-1, efa-2, nleG2-3, nleG5-2 and nleG6-2) were highly prevalent in eae-
positive strains (FIG III-2). However, these genes, with the exception of pagC, were 
less prevalent in eae-negative STEC (FIG III-2). Although 38.6% of eae-negative 
STEC strains were positive for pagC, its prevalence was significantly higher (64.8%) 
in eae-positive STEC (P=0.005). There was no apparent physical or functional 
relationship identified between OI-43/48 and LEE, but three OI-43/48 virulence 
genes (ureC, terC and aidA-1) were mainly associated with the presence of eae 
(P<0.0001). On the other hand, iha was more prevalent in eae-negative than in eae-
positive STEC strains (P=0.007). As for HPI, there were no significant differences in 






Phylogenetic analysis of iha from diverse pathogenic E. coli. A 
phylogenetic tree based on iha separated eae-positive and eae-negative STEC strains 
into two distinct clades (FIG III-3). In clade I, two subgroups, Ia and Ib, shared at 
least 98.0% sequence similarity. eae-positive EHEC serotypes highly associated with 
outbreaks and severe diseases were located in clade I (O157:H7, O26:H11, O103:H2, 
O111:NM, O145:H28). Those sequences shared at least 99% similarity and clustered 
together with iha from other pathogenic E. coli including enteropathogenic E. coli 
(EPEC), enteroinvasive E. coli (EIEC), eneteroaggregative E. coli (EAEC), 
enterotoxigenic E. coli (ETEC), uropathogenic E. coli (UPEC), neonatal meningitis 
E. coli (NMEC), and Shiga toxin-producing EAEC O104:H4 (from a German 
outbreak in 2011). iha sequences from the O26:H11, O111:H11, and O111:NM 
strains formed subgroup Ib and shared at least 98.0% sequence similarity with 
subgroup Ia. Interestingly, strains DEC10A (O26:H11), DEC10C (O26:H11), 11368 
(O26:H11) and DEC8C (O111:NM) carried two iha that clustered separately in Ia and 
Ib. 
All 15 iha sequences from eae-negative STEC clustered together to form 
clade II. Multiple sequence alignments demonstrated that iha from eae-negative 
STEC shared only 91.1-93.6% sequence similarity with iha from clade I. iha from 
subgroups IIa and IIb shared only 93.8-94.3% sequence similarity. As in some eae-
positive strains, eae-negative STEC strains CL-3 (O113:H21), 96.0497 (O91:H21) 
and B2F1 (O91:H21) also carried two iha genes that clustered separately in 





Phylogenetic and sequence analysis of pagC. The pagC phylogenetic tree 
showed four clades (FIG III-4). The eae-positive E. coli STEC formed a single clade 
with EPEC and ETEC, whereas the eae-negative STEC strains formed two clades, 
along with one strain that clustered with a Citrobacter rodentium strain. We identified 
15 single nucleotide polymorphisms (SNPs) and one indel among the 35 pagC 
sequences. Sequence analysis revealed that an insertion of adenine at nucleotide 388 
in two O103:H25, two O45:H2, one O103:H2 and one O103:H6 strains led to a frame 
shift mutation, and that a premature stop codon truncated the protein at the third loop 






In the present study, PAIs OI-122 and OI-57 of STEC were found highly 
associated with seropathotypes that can cause severe disease and outbreaks, as 
previously demonstrated (7, 13, 14). Several OI-122 virulence factors play important 
roles in bacterial pathogenesis. For example, PagC can promote the survival of 
Salmonella within macrophages (5, 9).  Efa is an adhesion protein originally 
described in some EHEC strains (27). The efa-1 gene is almost identical to lifA, an 
EPEC gene encoding lymphostatin (LifA) (28), which inhibits the proliferation of 
mitogen-activated lymphocytes and the synthesis of proinflammatory cytokines (28). 
Efa1/LifA also contributes to EPEC adherence to epithelial cells and is critical for the 
intestinal colonization by C. rodentium (29). NleB was required for full colonization 
and colonic hyperplasia in mice and a mutation of nleB abolished lethality of C. 
rodentium in C3H/HeJ mice (7, 30). 
Whereas OI-122 is highly related to colonization and suppression of the host 
immune system, the function of OI-57 is largely unknown. Wu et al. (15) determined 
that NleG like proteins including NleG2-3, NleG6-2 and NleG5-1 were E3 ubiquitin 
ligases, analogous to RING finger and U-box enzymes in eukaryotes. Although the 
targets of the OI-57 Nle effectors are unknown, several similar effectors are primarily 
involved in suppressing host immune response by degrading immune-related host 
proteins (15).  Thus, it is possible that OI-57, similar to OI-122, would be also related 
to suppression of host immune system. 
In addition to the virulence genes in OI-122 and OI-57, ureC and terC located 




and outbreaks. Urease has been confirmed as an important virulence factor in several 
bacterial species, such as Helicobacter pylori, Yersinia enterocolitica, Proteus 
mirabilis, Brucella species, and Klebsiella pneumonia (31).  Mutation of ureC has led 
to a reduced adherence of EHEC O157:H7 in ligated pig intestine (12).  A recent 
study by Steyert et al (32) revealed that strains with non-functional urease were two 
times unlikely to survive  passage through the stomach and had a reduced ability to 
colonize the mouse intestinal tract compared with urease-positive strains.  These data 
demonstrate that urease can help STEC strains survive in the stomach and enhance its 
competitiveness in colonization in calf and human intestinal tracts.  The role of 
tellurite resistance genes (terZABCDEF) in STEC is still not well understood. Yin et 
al (12) showed that mutation of the ter cluster in O157:H7 led to fewer adherence to 
epithelial cells and smaller bacterial clusters compared with wild-type strains. 
Therefore, ter genes might encode an adhesin or a gene product that promotes the 
function of adhesion(s). In addition, tellurite salts are strong oxidative agents, and it is 
possible that ter genes might offer a selective advantage in the host environment and 
aid STEC in general stress response (12). 
Interestingly, ureC has been more frequently found in eae-positive STEC 
(113/132) than in eae-negative strains (4/70) although no physical linkage of ureC 
and eae has been identified (33). The prevalence of ureC in eae-positive STEC 
(45/55) was significantly higher than in eae-negative STEC (2/44) (P< 0.0001).  
Similarly, terC was also more prevalent in eae-positive STEC (45/55) than eae-




distant, our observations indicated that there might be a functional relationship 
between LEE and OI-43/48.  
The arrangement of OI-122 genes was found to be serotype dependent and all 
O157:H7 strains have a complete OI-122 (5, 9). However, we found that two patterns 
of OI-122 existed in O157:H7. An incomplete OI-122 lack of third module was 
identified in all GUD-positive O157:H7 strains.  Additionally, aidA-1 of OI-43/48 
was absent in GUD-positive O157:H7.   
Most OI-122, OI-43/48 and OI-57 virulence genes (pagC, sen, nleB, efa-1, 
efa-2, terC, ureC, iha, aidA-1, nleG2-3, nleG6-2, and nleG5-2) were highly prevalent 
in eae-positive STEC. However, they were largely absent in eae-negative STEC with 
the exception of pagC and iha. Phylogenetic analysis revealed that iha genes from 
eae-positive STEC had high similarity (99.6%), whereas they had lower sequence 
similarity (91.1-93.6%) with iha genes from eae-negative STEC, indicating that iha 
from eae-positive and eae-negative STEC may have evolved independently or have 
different origins. Such a difference also existed in pagC between eae-positive and 
eae-negative STEC.  Schemidt et al (34) reported that iha was carried by a 33,014 bp 
PAI in STEC serotype O91:H- strains (eae-negative). In addition, iha was found in 
pO113 plasmid of STEC serotype O113:H21 (eae-negative) (35).  Moreover, Shen et 
al (36, 37) reported that pagC was identified within a mosaic PAI from 
STECO113:H21strain CL-3 (eae-negative). Thus, the higher prevalence of iha and 
pagC in the eae-negative STEC strains, as compared with other virulence marker 
genes in this study, is likely due to the presence of the same or similar PAIs and/ or 




seropathotypes highly associated with severe diseases and other seropathotypes 
indicates that iha is not related with severe clinical outcomes, but the significantly 
higher prevalence of pagC in the seropathotypes associated with severe diseases 
indicates that this gene has some association with severe clinical outcome whether a 
strain carries the gene in OI-122 or in some other PAIs.  
The distribution of PAI virulence genes and the phylogenetic analysis of iha 
and pagC support the hypothesis that OI-122, OI-43/48 and OI-57 are primarily 
associated with eae-positive strains in STEC. However, some eae-negative STEC 
serotypes, for example, O113:H21 and O91:H21, are also associated with life 
threatening diseases such as HUS (5).  Virulence factors such as subtilase cytotoxin 
AB5 (subAB5) and Saa (STEC autoagglutinating adhesion) are more commonly 
associated with eae-negative STEC. Moreover, it has been shown that some LEE-
negative STEC, especially O113:H21, can invade tissue culture cells (38).Whole 
genome comparison between nine eae-negative and five eae-positive STEC strains 
revealed that eae-negative strains did not carry any LEE or other phage encoded non-
LEE effectors (39).  These observations indicate that some differences in 
pathogenesis mechanisms may exist between eae-positive and eae-negative STEC. 
Additional studies, especially genomics and proteomics, are needed to unveil the 
difference in the pathogenicity mechanisms between eae-negative and eae-positive 
STEC.  
The strong association of OI-122, OI-57 and OI-43 with eae-positive STEC 
offers an important basis for STEC molecular risk assessment (MRA). The MRA, 




risk non-O157 STEC, was proposed by Coombes et al  in 2008 (13). Other 
researchers adopted this concept and applied it to their own studies (40-43). However, 
the current work demonstrated that some of non-LEE encoded effectors (nleB, nle2-3, 
nleG5-2 and nleG6-2) were primarily associated with eae-positive STEC strains. In 
addition, Mundy et al (44) reported that nleA was present in 37 out of 43 (86%)  eae-
positive STEC, but absent in 50 eae-negative STEC clinical strains. Konczy et al (9) 
reported that nleB and nleE of OI-122 were highly correlated with LEE. Moreover, 
comparative genomics analysis demonstrated that all known phage encoded non-LEE 
effector genes were absent in eae-negative STEC (39).  Based on the MRA 
framework, which uses non-LEE effector genes as sole markers, all eae-negative 
virulence STEC, including HUS associated O113:H21, O91:H21 and O104:H21, 
would be grouped as harmless STEC; other serotypes, for example, O103:H11 and 
O119:H25, which have not been reported as associated with severe disease or 
outbreaks but carry similar non-LEE encoded virulence effectors as O157 EHEC, 
would be considered as outbreak- and severe disease-associated serotypes. Therefore, 
additional markers or methods of assessment, especially for eae-negative STEC, are 
needed to accurately distinguish highly pathogenic STEC from low virulent or 
harmless STEC.  
In summary, O-122 and OI-57, and their virulence genes were highly 
associated with seropathotypes that cause severe diseases and outbreaks. In addition, 
ureC and terC located at OI-43/48 were also identified as markers related to high risk 
seropathotypes. Virulence genes in PAIs that are associated with severe diseases can 




study demonstrated that OI-122, OI-43/48, and OI-57 are highly associated with eae-
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TABLE II1-1. Distribution of eae subtypes, and virulence genes of OI-122, OI-43/48, OI-57 and high pathogenicity island 






                                                                                        
eae subtype 
 
No. of  
No. of strains positive by PCR for 
  
 strains   pagC      sen     nleB        efa-1           efa-2        terC         ureC          iha       aidA-1      nleG2-3      nleG5-2     nleG6-2       fyuA            irp2 
  
  
              
A O157:H7 GUD-* Gamma 1 4 5 5 5 5 5 5 5 5 5 5 5 5 0 0 
 
O157:H7 GUD+ Gamma 1 5 5 5 5 0 0 5 5 5 0 5 5 5 0 0 
 
O157:NM Gamma 1 6 6 6 6 6 6 0 0 0 0 6 6 6 0 0 
B O26:H11 Beta 4 0 4 4 4 4 4 4 4 3 4 4 4 4 4 
 
O103:H2 Epsilon1 4 2 4 4 4 4 2 2 1 2 4 1 2 0 0 
 
O111:H8/NM Gamma2/theta 4 3 4 4 4 4 4 4 4 0 4 3 4 2 2 
 
O121:H19 Epsilon1 3 3 3 3 3 3 3 3 0 0 3 3 3 0 0 
 
O145:H28/NM Gamma1 4 1 4 4 3 3 4 4 4 4 3 2 3 0 0 
C O5:NM Beta 1 1 1 1 1 1 1 1 0 0 1 0 0 0 0 
 
O22:H5 negative 1 0 0 0 0 0 0 0 0 1 0 0 0 1 1 
 
O22:H8 negative 2 1 0 0 0 0 0 0 2 0 0 0 0 0 0 
 
O45:H2 Epsilon1 4 4 4 4 4 4 4 4 0 4 4 3 3 0 0 
 
O50:H7 Epsilon1 1 1 1 1 1 1 1 1 0 0 1 1 1 0 0 
 
O55:H7 Gamma 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 
 
O91:H21 Negative 1 1 0 0 0 0 0 0 1 0 0 0 0 0 0 
 
O104:H21 Negative 1 1 0 0 0 0 0 0 1 0 0 0 0 0 0 
 
O113:H21 Negative 4 4 0 0 0 0 0 0 4 1 0 0 0 0 0 
 
O118:H16 Beta 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 
 
O125:NM Beta 1 0 1 1 1 1 1 1 0 0 0 0 0 0 0 
 
O128:H2 Beta 1 0 0 0 0 0 0 0 1 1 0 0 0 1 1 
 
O128:H45 Negative 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 
 
ONT:H2 Negative 1 1 0 0 0 0 0 0 1 0 0 0 0 0 0 
 
OUN:NM Negative 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 





O15:H27 Negative 1 0 0 0 0 0 0 0 1 0 0 0 0 1 1 
 
O91:H14 Negative 4 4 0 0 0 0 0 0 4 0 0 0 0 0 0 
 
O91:H7 Negative 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 
 
O103:H11 Beta 2 2 2 2 2 2 1 1 2 2 2 2 2 2 2 
 
O103:H25 Gamma2/theta 3 3 3 3 3 3 3 3 0 3 2 0 2 0 0 
 
O111:H11 Beta 4 0 4 4 4 4 4 4 4 3 4 4 4 4 4 
 
O116:H21 Negative 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 
 
O126:H8 Negative 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 
 
O146:H21 Negative 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 
 
O174:H8 Negative 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 
E O8:H16 Negative 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 
 
O8:H28 Negative 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 
 
O15:H16 Negative 1 0 0 0 0 0 0 0 0 0 0 0 1 1 1 
 
O36:H14 Negative 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
 
O46:H38 Negative 1 0 0 0 0 0 1 0 1 0 0 0 0 0 0 
 
O73:H18 Negative 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 
 
O83:H8 Negative 7 3 0 0 0 0 2 0 3 0 0 0 0 0 0 
 
O88:H38 Negative 1 1 0 0 0 0 0 0 1 0 0 0 0 0 0 
 
O88:H49 Negative 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 
 
O113:H36 Negative 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
 
O128:H16 Negative 4 2 2 2 4 2 2 2 4 4 4 2 3 4 4 
 
O168:H8 Negative 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
 








TABLE III-2. Distribution of pathogenicity islands (PAIs) in seropathotypes associated outbreak (SPT A and B) and severe 
disease (SPT A, B and C). 
 
  Association of PAIs with seropathotypes  
related to outbreak 
Association of PAIs with seropathotypes  
related to severe disease 
PAIs Prevalence (%) 
in SPT A and B 
(n=34)  
Prevalence  (%) in  
SPT C, D and E (n=64) 
Prevalence (%) in SPT 
A, B and C (n=56) 
Prevalence  (%) in 




















HPI 17.65  25.00 17.86 28.57 
*: Statistically significant difference between SPT A and B with SPT C, D and E.  +: Statistically significant difference between SPT A, B and C with SPT D and E.  A P value less than 0.01 is 
















TABLE III-3. Distribution of virulence genes located at pathogenicity islands (PAIs) in seropathotypes associated outbreak 
(SPT A and B) and severe disease (SPT A, B and C). 
 
  
Association of virulence genes 
 with seropathotyps related to outbreak 
Association of virulence genes 
with seropathotyps related to severe disease 
Gene PAIs Prevalence (%) in  
SPT A and B (n= 34) 
Prevalence  (%) in SPT 
C, D and E (n=64) 
Prevalence (%) in STEC 
SPT A, B and C (n=56) 
Prevalence (%) in STEC 
in SPT D and E (n=42) 



























































Iha OI-43/48 64.70 70.31 64.29 73.80 




























fyuA HPI 17.65 23.44 16.07 28.57 
irp2 HPI 17.65 23.44 16.07 28.57 
*: Statistically significant between SPT A and B with SPT C, D and E.  +: Statistically significant between SPT A, B and C with SPT D and E.  A P value less than 0.01 is 
























TABLE III-4.  Characterization and presence of PAIs associated virulence genes among O157:H7 and O157:NM  
 
 
        OI-122 OI-43/48 OI-57 HPI 
Strains Serotype stx GUD* pagC sen efa-1 efa-2 nleB terC ureC iha aid-1 nleG2-3 nleG6-2 nleG5-2 irp2 fyuA 
EC4115 O157:H7 stx1,stx2  -  + + + + + + + + + + + + - - 
Saika O157:H7 stx1, stx2  -   + + + + + + +  + + + + + - - 
TW14359 O157:H7 stx1, stx2  -    + + + + + + +  + + + + + - - 
FDA413 O157:H7 stx2  -    + + + + + + +  + + + + + - - 
1628 O157:H7 stx1,stx2  +    + + -  - + + +  + - + + + - - 
1659 O157:H7 stx1,stx2  +     + + -  - + + +  + - + + + - - 
EC97144 O157:H7 stx1,stx2  +     + + -  - + + +  + - + + + - - 
EC96038 O157:H7 stx1,stx2  +     + + -  - + + +  + - + + + - - 
EC96012 O157:H7 stx1,stx2  +     + + -  - + + +  + - + + + - - 
493/89 O157:NM stx2  +     + + + + + - - - - + + + - - 
5412/89 O157:NM stx2  +      + + + + + - - - - + + + - - 
IH56929 O157:NM stx2  +      + + + + + - - - - + + + - - 
IH56909 O157:NM stx2  +      + + + + + - - - - + + + - - 
H1085C O157:NM stx2  +      + + + + + - - - - + + + - - 
H2687 O157:NM stx2  +      + + + + + - - - - + + + - - 




FIG III-1. Distribution of OI-122, OI-43/48, OI-57 and high pathogenicity island 























FIG III-2. Distribution of virulence genes located on OI-122, OI-43/48, OI-57 
and high pathogenicity island (HPI) between eae-positive (n=54) and eae-























FIG III-3. Phylogenetic tree based on iha sequences from 67 E. coli and Shigella 
strains. 
iha sequences were aligned and a tree was constructed using the maximum likelihood 
method with 2,000 iterations utilizing MEGA 5.05 (26). iha sequences from eae-
positive and eae-negative STEC strains segregated into two distinct clades, clades I 
(with subgroup Ia and Ib) and II (with subgroups IIa and IIb). iha sequences from 
eae-negative STEC were marked in bold and italic, and eae-positive STEC strains 
were marked in bold. EPEC: enteropathogenic E. coli; EIEC: enteroinvasive E. coli; 
EAEC: eneteroaggregative E. coli; stx-producing EAEC: Shiga toxin-producing 
EAEC; ETEC: enterotoxigenic E. coli; UPEC: uropathogenic E. coli; NMEC: 















FIG III-4. Phylogenetic tree based on pagC sequences from 34 pathogenic E. coli 
strains. 
pagC sequences were aligned and a tree was constructed using the maximum 
likelihood method with 2,000 iterations utilizing MEGA 5.05 (26). pagC sequences 
from eae-negative STEC were marked in bold and italic, and eae-positive STEC 
strains were marked in bold. pagC genes sequenced by this study were marked by 






CHAPTER IV: PHYLOGENETIC ANALYSIS OF NON-
O157 SHIGA TOXIN-PRODUCING ESCHERICHIA COLI 
BY WHOLE GENOME SEQUENCING 
Abstract 
Non-O157 Shiga toxin-producing Escherichia coli (STEC) are emerging 
foodborne pathogens causing life threatening diseases and foodborne outbreaks. A 
better understanding of their evolution provides a framework for developing tools to 
control food safety. We obtained 15 genomes of non-O157 STEC strains, including 
O26, O111 and O103. Phylogenetic trees revealed close relationship between 
O26:H11 and O111:H11 and a scattered distribution of O111. We hypothesize that 





Shiga toxin-producing Escherichia coli (STEC) are deadly pathogens, causing 
hemorrhagic colitis (HC) and hemolytic uremic syndrome (HUS) (1, 2). There are 
two categories of surface antigens (O somatic and H flagella), whose combinations 
are used to classify E. coli. O157:H7 has caused more outbreaks and HUS cases in 
the United States than any other STEC serotypes. However, there is a growing 
concern about the health risk of non-O157 STEC (3) as more than 470 serotypes of 
STEC are associated with human diseases (4). In the United States, non-O157 STEC 
cause an estimated 112,752 cases of illness each year, which is more than the number 
of cases (estimated 63,153) caused by E. coli O157:H7 (5).  
Worldwide, six serogroups including O26, O45, O103, O111, O121 and O145 
are most commonly isolated from human patients. Among the non-O157 STEC, 
serogroups O26, O111 and O103 are considered the most clinically important and 
frequently identified non-O157 STEC in severe diseases and foodborne outbreaks (6-
8).  
As emerging foodborne pathogens, the phylogentic relationship of STEC is 
not well understood. In this study, we used whole genome sequencing data to 
examine phylogenetic relationship of non-O157 STEC strains for a better 




Materials and Methods 
Bacteria Strains.  Fifteen STEC strains representing different PFGE patterns, 
isolation years, hosts, and stx gene profiles, including O26:H11 (5), O111:H11 (3), 
five O111:H8 (5), O103:H2 (1), and O103:H25 (1) were used in this study (Table 1). 
In addition, 28 E. coli genomes downloaded from the GenBank were included for 
phylogenetic study. 
Pulsed field gel electrophoresis (PFGE). PFGE with XbaI was performed 
following a non-O157 PulseNet protocol 
(http://www.pulsenetinternational.org/SiteCollectionDocuments/pfge/5%201_5%202
_5%204_PNetStand_Ecoli_with_Sflexneri.pdf). Salmonella Braenderup H9812 was 
used as control for PFGE. All the PFGE gel pictures were analyzed using 
BioNumerics software (Applied Maths, Austin, TX).  Unweighted pair group means 
with arithmetic averages (UPGMA) was used to construct a dendrogram with a 1.5% 
band position tolerance.   
eae subtyping. eae subtypes were determined using PCR-RFLP as described 
by Tramuta et al (9). The following strains were used as positive controls: EDL933 
(gamma), TW06584 (kappa), E2348-69 (alpha), TW07920 (epsilon), RDEC-1 (beta), 
TW10366 (rho), TW0350 (iota), TW07892 (eta), and TW01387 (theta).  E. coli K12 
was used as negative control. 
Multiplelocus sequence typing. Seven housekeeping genes (aspC, clpX, 
fadD, icdA, lysP, mdh, and uidA) extracted from genomes were selected for 




E. coli (http://www.shigatox.net/ecmlst/protocols/index.html). The MLST analysis 
was performed using MEGA 5.05 (10) with 2,000 iterations (model: maximum 
composite likelihood; substitution: transitions + transversions; Gamma). 
Whole genome sequencing. The whole genome DNA of selected STEC 
strains were extracted with the DNeasy Blood & Tissue Kit (Qiagen, Valencia, CA) 
according to the manufacturer’s instructions. Roche 454 GS-FLX+ system (Roche, 
Branford, CT) was used to perform DNA shotgun sequencing  to obtain ~ 20 × 
coverage of draft genomes. The Roche Newbler (v 2.6) software package was used to 
conduct de novo assemblies. Multiple sequence alignment of all 43 genomes was 
performed using MAUVE (11). SNPs was extracted from the multiple sequence 
alignment and concatenated into pseudosequences by MAUVE. To further explore 
evolutionary relatedness, a parsimony phylogenetic tree based on whole genome wide 








Pulsed field gel electrophoresis and eae subtyping. The 15 STEC strains 
were grouped into two main clusters (FIG IV-1) that separated H11 strains 
(O111:H11 and O26:H11) from H8 strains (O111:H8). However, PFGE was not able 
to differentiate O111:H11 and O26:H11. In addition, the O26:H11 and O111:H11 
strains shared the same eae subtype (ß), while the O111:H8 strains contained . It 
appeared that O111:H11 and O26:H11 were more closely related to each other than 
either was to O111:H8, according to PFGE profiles and virulence genes associated 
elements in the genomes.  
Multi-locus sequence typing. In the MLST phylogenetic dendrogram, all the 
O111:H11, O26:H11 and O111:H8 strains formed one branch, with O26:H11 and 
O111:H11 clustering together in a lineage sister to the O111:H8 strains (FIG IV-2). It 
is interesting that O26:H11 strain DEC10B clustered with the O111:H11 strains, 
which also indicates the close relatedness between O26:H11 and O111:H11. 
Furthermore, five strains (12009, CVM9450, E22, DEC12C, and 03-EB-705) sharing 
the H2 antigen clustered together regardless of O serotypes. Genomic analysis 
revealed that O111:NM strain DEC12C carried fliC for the H2 gene.  
Whole genome wide single nucleotide polymorphisms (SNPs) 
phylogenetic tree. The genome sizes of the 15 STEC strains ranged from 5.26 Mbp 
to 6.01 Mbp (Table IV-1). In order to analyze the phylogenetic relationship between 
non-O157 STEC, 28 E. coli genomes of various pathogenic E. coli including STEC, 
enteropathogenic E. coli (EPEC), enteroinvasive E. coli (EIEC), eneteroaggregative 




O104:H4 (from a German outbreak in 2011) downloaded from the GenBank were 
included for phylogenetic study. Multiple sequence alignment of all 43 genomes was 
performed using MAUVE (11) and approximately 183,470 single nucleotide 
polymorphisms (SNPs) were identified. Similarly as data shown by PFGE and 
MLST, the phylogenetic tree demonstrated that O26:H11 strains belonged to the same 
clade as the O111:H11 and O111:H8 strains, but grouped more closely with strains of 
the same H type (O111:H11) (FIG IV-3). All O111 strains but O111:H2 formed one 
clade (FIG IV-3), including O111 EPEC, O111:H8 and O111:H11. Additionally, we 
reconstructed maximum likelihood (ML) tree by Garli-2.0 (13) and Bio Neighbor 
Joining (BioNJ) (14) tree using SeaView 4 (15) (data not shown), displaying similar 
phylogenetic relationship with TNT tree with minor differences. For example, in the 
BioNJ tree, E. coli O26:H11 DEC10B grouped with the O26:H11 strains. The H2 
strains including O103:H2, O45:H2 and O111:H2 strains were closely clustered 
together in all phylogenetic trees, including TNT, ML and BioNJ trees as shown in 
MLST dendrogram. The phylogenetic trees also supported that STEC O113:H21 and 









Shiga toxin-producing E. coli are among the most important emerging 
foodborne pathogens. Recently, more and more outbreaks and sporadic disease are 
related to diverse serotypes of STEC. Among all the non-O157 STEC, O26, O103 
and O111 cause most known outbreaks and HUS diseases. In this study, 15 STEC of 
O26, O103 and O111 from human and animals were sequenced. The phylogenetic 
trees were constructed to determine the evolutionary relationship of non-O157 STEC.   
In this study, MLST, PFGE and whole genome wide SNP trees indicating that 
the H11 strains, including O26:H11 and O111:H11 (Figure IV-2 and IV-3) shared 
common ancestor; the H2 strains with different O antigens, namely, H2 group in 
Figure 3, shared common ancestor as well. Previous studies also have suggested that 
STEC strains with the same H antigens might share common ancestors. For example, 
Iguchi et al. (16) indicated that a close relatedness between STEC O103:H11 and 
O26:H11 by MLST analysis, which shared the same eae subtype (ß-eae) that was also 
inserted at the same t-RNA locus (pheU-tRNA). The O111:H11 strains used in this 
study also carry ß-eae as well (Figure 1). In addition, Konczy et al. (17) and Ziebell et 
al. (18) demonstrated that STEC O69:H11 was found closely related to O26:H11. 
Additionally, Konczy et al. (17) reported that H25 STEC strains (O103:H25, 
O119:H25, and O98:H25) and H21 STEC strains (O91:H21, O113:H21, O146:H21 
and ONT:H21) were clustered together, separately, based on MLST. These data and 
our findings provided strong evidence that some STEC strains with common H 
antigens appear to originate from common ancestors. It is interesting that the four H 




O103:H2, O103:H25, O45:H2, O91:H21 and O113:H21, which have been identified 
among the most important non-O157 STEC associated with outbreaks and HUS. 
Thus, it is possible that some most clinical and epidemic STEC serotypes with same 
H antigens might have evolved from common ancestors, respectively. It is possible 
that ancestral strains of those H groups share similar or same genetic background 
and/or environmental niche that could facilitate acquisition of stx and other virulence 
genes essential to STEC pathogenesis. 
Our phylogenetic analyses demonstrated that the H groups were monophyletic 
while the serogroups were polyphyletic (FIG IV-3). Scattered distribution of different 
O111 strains suggested that strains from individual lineages might have acquired 
surface antigen genes independently in an ongoing parallel evolutionary process, such 
as E. coli O111:H21 DEC15E (O111 EPEC group), E. coli O111:H2 E22 (H2 group), 
E. coli O111:H8 CVM9634 (O111:H8 group) and E. coli O111:H11 CVM9545 
(O111:H11 group) (Figure 3). Iguchi et al. (16) suggested that STEC O103:H2, 
O103:H11 and O103:H25 formed three different linages by MLST analysis and had 
distinct eae subtypes. The MLST and SNP phylogenetic trees in this study also 
supported that O103:H2 and O103:H25 were located at different linages (FIG IV-2 
and FIG IV-3). Thus, just using serogroups may cause misleading conclusion about 
phylogenetic relatedness and health risk of STEC. 
Pairwise distance matrix analysis with 2,000 bootstrap iterations (substitution: 
transitions + transversions; complete-delete option) (TABLE IV-2) were conducted to 
determine number of SNPs differences (standard deviation) between different 




O111 groups. The values of base differences per sequence from averaging over all 
sequence pairs between groups were shown. The smallest distance value was found 
between O111:H11 and O26:H11 strains, confirming their close relatedness. Previous 
studies indicated that O157:H7 evolved from O55:H7 in a series of steps acquiring 
O157 antigen gene cluster and other virulence genes through HGT (19-22). The 
distance between O157:H7 Sakai and O55:H7 CB9615 was 4215 SNPs with a 
standard deviation of 37. Because O26:H11 strains located in the O111 clade in 
phylogenetic trees and display closer relationship with O111:H11 than O111:H8, it is 
possible that O26:H11 evolved similarly from an ancestral O111:H11 by antigenic 
shift from O111 to O26 (distance between O26:H11 and O111:H11 groups was 3617, 
Table 2). Sharing the same niche with other O26 strains may facilitate this genetic 
exchange. Comparative genomics analysis of O26:H11, O111:H11 and other STEC is 
underway to reveal the possible mechanism. 
In conclusion, analyses based on whole genome wide SNPs, MLST, and 
PFGE suggest that in some occasions O serogroups appear not to track evolutionary 
relatedness among pathogenic E. coli. Instead, H antigens may be better markers of 
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TABLE IV-1. Serotypes, pathotypes, toxin genotypes, sources and genome sizes of Escherichia coli strains used in this study*. 
 
Strain Serotype Pathotype§ stx Source Size (Mbp) Accession No. 
CVM10021 O26:H11 STEC stx1 cow 5.5 AKAZ00000000 
CVM9942 O26:H11 STEC stx1 cow 5.62 AJVW00000000 
CVM10026 O26:H11 STEC stx1 cow 5.57 AJVX00000000 
CVM10030 O26:H11 STEC stx1 cow 5.5 AKBA00000000 
CVM9952 O26:H11 STEC stx1 pig 5.5 AKBC00000000 
CVM9634 O111:H8 STEC stx1+stx2 cow 5.78 AKAW00000000 
CVM9602 O111:H8 STEC stx1 human 5.1 AKAV00000000 
CVM9574 O111:H8 STEC stx1+stx2 human 5.36 AJVV00000000 
CVM9570 O111:H8 STEC stx1+stx2 cow 5.51 AJVU00000000 
CVM9545 O111:H11 STEC stx1 cow 5.61 AJVT00000000 
CVM9455 O111:H11 STEC stx2 unknown 6.01 AKAX00000000 
CVM9534 O111:H11 STEC stx1 cow 5.46 AJVS00000000 
CVM9553 O111:H11 STEC stx1 cow 5.6 AKAY00000000 
CVM9340 O103:H25 STEC stx1 human 5.26 AJVQ00000000 
CVM9450 O103:H2 STEC stx1 human 5.39 AJVR00000000 
CFT073 O6:K2:H1 UPEC - unknown 5.23 AE014075 
SAKAI O157:H7 STEC stx1+stx2 human 5.59 BA000007 
CB9615 O55:H7 EPEC - human 5.39 NC_013941 
4865/96 O145:H28 STEC stx2 human 5.23 AGTL00000000 
53638 O144:? EIEC - unknown 5.07 AAKB00000000 
101-1 O-:H10 EAEC - human 4.98 AAMK00000000 
MG1655 Unknown Commensal - unknown 4.64 NC_000913 




TY-2482 O104:H4 EAEC+STEC stx2 human 5.29 AFOG00000000 
CL-3 O113:H21 STEC stx2 human 5.05 AGTH00000000 
B2F1 O91:H21 STEC stx2 human 5.01 AGTI00000000 
E24377A O139:H28 ETEC - unknown 4.97 NC_009801 
DEC12B O111:H2 STEC stx2 human 5.49 AIHB00000000 
DEC12C O111:NM STEC stx2 human 5.45 AIHC00000000 
E22 O103:H2 EPEC - unknown 5.53 AAJV00000000 
03-EN-705 O45:H2 STEC stx1 human 5.3 AGTK00000000 
12009 O103:H2 STEC stx1+stx2 human 5.45 NC_013353 
E110019 O111:H9 EPEC - human 5.38 AAJW00000000 
DEC15A O111:H21 EPEC - human 5.25 AIHO00000000 
DEC15E O111:H21 EPEC - human 5.23 AIHS00000000 
DEC8E O111:H8 STEC stx1 human 5.32 AIGJ00000000 
DEC8B O111:H8 STEC stx1+stx2 human 5.37 AIGG00000000 
11128 O111:H- STEC stx1+stx2 human 5.37 NC_013364 
DEC8D O111:H11 DEC - human 5.46 AIGI00000000 
DEC8C O111:H11 STEC stx1 cow 5.91 AIGH00000000 
DEC10B O26:H11 STEC stx1 human 5.58 AIGQ00000000 
EPECa14 O26:H11 STEC stx1 unknown 5.44 ADUN00000000 
11368 O26:H11 STEC stx1 human 5.69 NC_013361 
* Data on strains named with CVM were from this study; the rest were from GenBank. 
§
STEC: Shiga toxin-producing Escherichia 
coli ; EPEC: enteropathogenic Escherichia coli ; EIEC: enteroinvasive Escherichia coli ; ETEC: enterotoxigenic Escherichia coli ; 









negative  H2  O111 EPEC  O111:H8  O111:H11  
H7        
eae
 
negative  57246 (107)      
H2  58029 (139) 21523 (77)     
O111 EPEC  59530 (105) 23107 (98) 23442 (113)    
O111:H8  59498 (126) 23993 (75) 22558 (97) 21427 (83)   
O111:H11  59417 (113) 24157 (98) 22717 (123) 21512 (84) 4324 (35)  
O26:H11  57176 (108) 21913 (78) 22138 (107) 24045 (102) 6556 (42) 3617 (37) 












Figure IV-1. Dendrogram of PFGE profiles of 15 O26, O103 and O111 STEC isolates.  
Similarity of the PFGE profiles was based on Dice algorithm with 1.5% tolerance. O26:H11 and O111:H11 strains showed close 











Figure IV-2. Dendrogram of MLST analyses using aspC, clpX, fadD, icdA, lysP, mdh, and uidA.  
Strains 4865/96 (O145:H28), 101-1(O-:H10), 5.0959 (O121:H19), DEC12B (O111:H2) and E110019 (O111:H9) were not included in 








Figure IV-3. Parsimony phylogenetic tree of 43 E. coli from diverse pathotypes 
based on genome wide single nucleotide polymorphisms (SNPs) with 10,000 
iterations.  
Strains sequenced in this study were marked within frame. A total of seven subgroups 







 CHAPTER V:  SUMMARY AND FUTURE STUDY 
 
Shiga toxin–producing Escherichia coli (STEC) are emerging foodborne 
pathogens.  There are at least 470 serotypes that have been reported associated with 
human illness.  In the United States and worldwide, the report of incidences of non-
O157 infections and foodborne outbreaks are continuously increasing.  However, 
non-O157 STEC are generally not well studied. The objective of this study was to 
determine the prevalence of non-O157 STEC in retail meat and explore its 
pathogenicity islands distribution and evolutional relationship. 
In chapter II, the prevalence and characterization of non-O157 STEC from 
retail meat were determined. Meat products, especially from cattle, can serve as 
vehicles in transmitting STEC to humans. Although the presence and characterization 
of O157 STEC has been very well studied, limited information is available about non-
O157 STEC contamination in retail meat in the United States. Therefore, the first 
objective of this study was to determine the prevalence and characterization of non-
O157 STEC from retail meats.  Since no standard non-O157 STEC isolation method 
was available when this study started, a combination of a modified USDA MLG 
method was used to isolate non-O157 STEC from retail ground beef and pork.  In 
total, 13 out of 271 beef and 12 out of 231 pork samples were positive for non-O157 
STEC. Thirty-two non-O157 STEC isolates were recovered from beef (16) and pork 
(16). Although none of 32 non-O157 isolates were positive for eae, 12 were positive 
for stx2dact, which is one of most prevalent stx subtypes in eae-negative STEC 




from beef were identified as O91 by PCR. O91 is a one of most commonly isolated 
serogroups from clinical samples.  In addition, cytotoxicity assay demonstrated that 
26 (81.3%) isolates produce Shiga toxin(s) that can cause cell damage to Vero cells. 
Besides, 17 (53.1%) isolates could resist two or more antimicrobials, which suggested 
that antimicrobial resistance is common among non-O157 STEC from retail meat. 
In chapter III, distribution of pathogenicity islands (PAIs) was characterized 
in non-O157 STEC. Although the stx gene is the primary virulence factor of STEC, 
however, it was not a suitable marker to distinguish highly pathogenic with 
nonpathogenic or low pathogenic strains. Instead, pathogenicity island (PAI), which 
is normally highly prevalent in high pathogenic strains but almost absent in non-
pathogenic strains of the same or closely related species, may be used as a marker to 
distinguish non-O157 STEC linked to severe disease with nonpathogenic or low 
pathogenic strains. In addition, PAI can also be used as a signature to identify new 
and emerging pathogenic STEC.  Although some of other virulence genes have been 
identified associated with outbreaks and severe disease, the clear distribution of 
pathogenicity islands in non-O157 STEC and its association with diseases and 
outbreaks is still missing. In chapter III, 98 STEC strains were classified into 
seropathotypes A to E based on the association of individual serotype with diarrhea, 
severe diseases and outbreaks. PCR-RFLP was used to determine the eae and stx 
subtypes. Fourteen PCR targeting virulence genes located at different regions of an 
individual PAI were used to determine the presence of PAIs.  OI-122 and OI-57 were 
identified as PAIs more prevalent in seropathotypes (SPT A, B and C) associated with 




terC, virulence genes located at OI-43/48, were also identified as statistically more 
prevalent in SPT A, B and C (associated with severe diseases). However, the high 
pathogenicity island, crucial for pathogenesis in Yersinia, was missing in SPT A 
(O157) and distributed evenly in SPT B, C, D and E. In summary, all the statistical 
comparisons indicated that OI-122, OI-57 and OI-43/48 might contribute to the non-
O157 pathogenesis process and may be used as markers to predict highly pathogenic 
non-O157 in the future.  
In addition, the association of OI-122, OI-57, OI-43/48 and HPI with LEE 
was analyzed in chapter III. Statistical analysis demonstrated that almost all virulence 
genes of OI-122, OI-57 and OI-43/48 were highly associated with eae, the marker 
gene for the presence of LEE. Although iha and pagC were highly prevalent in both 
eae-positive and eae-negative STEC, phylogenetic demonstrated that the two genes 
were separated with each other between eae-positive and eae-negative STEC, 
indicating that they may have different origins or have been separated a long time 
ago. In summary, both statistical analysis and phylogenetic studies indicated that eae-
positive and eae-negative STEC may have huge differences in their pathogenic 
mechanisms. Additionally, the association of PAIs (OI-122, OI-57, OI-43/48 and 
LEE) with eae-positive STEC but almost missing in eae-negative STEC suggested 
that a complete different marker gene may need to conduct molecular risk assessment 
for eae-negative STEC in the future.  
Besides LEE, OI-122, OI-57 and OI-43/48, there are seven other potential 
pathogenicity islands that were identified based on genomic and bioinformatics study 




and ClpB-like chaperone; OI-28 contains genes encoding a RTX-toxin-like 
exoprotein and transport system; OI-47 encodes genes that have potential function as 
an adhesion and polyketide or fatty-acid biosynthesis system; OI-84 carries genes 
encoding O antigen polysaccharide; OI-108 encodes the adhesion-like auto-
transporter, and the ATP binding component of a transport system; OI-115 carries 
genes for a type III secretion system and secreted proteins similar to the Salmonella-
Shigella inv-spa host cell invasion genes; and OI-138 carries genes that function as a 
fatty-acid biosynthesis system. Those islands may be used as additional markers to 
distinguish highly pathogenic STEC with others. Currently, the developing of next 
generation sequencing and the small size of bacteria makes whole genome 
sequencing a relative cheap study tool for bacteria. A future whole genome study to 
determine the distribution of these potential PAIs may help us clearly identify the 
association of PAIs with different non-O157 STEC and also determine new markers 
to distinguish highly pathogenic STEC with low pathogenic ones.  
In addition, as indicated by this study, the distribution of pathogenicity islands 
is totally different between eae-positive and eae-negative STEC. Genomic studies, 
especially comparative genomics study between eae-positive and eae-negative STEC, 
can help to fully unveil the infection mechanism difference between eae-negative and 
eae-positive. 
In chapter IV, the phylogenetic relationship of non-O157 was analyzed by 
PFGE, multi-locus sequence typing (MLST), and whole genome wide single 




especially for non-O157, has not been unveiled in STEC. Among non-O157 STEC, 
O26, O111 and O103 are the serogroups that caused most of the known outbreaks and 
identifying its phylogenetic relationship is important for understanding their evolution 
and non-O157 STEC pathogenesis. In this study, a total of 15 STEC strains 
representing isolation years, hosts, and stx gene profiles, including O111:H11, 
O111:H8, O26:H11, O103:H2, and O103:H25, were selected for whole genome 
sequencing analysis using a 454-pyrosequencing system to obtain draft genomes. In 
addition, 28 pathogenic E. coli genomes, 16 of which belong to STEC, were used to 
analyze the phylogenetic relationship of STEC.  PFGE, MLST and the whole genome 
level SNP study indicated that O26:H11 were closely related with O111:H11 and may 
have a common ancestor. WGS SNP analysis also indicated that O45:H2 and 
O1O3:H2 may also evolve from a common ancestor.  
 Compared with O26:H11, O111:H11 was much less commonly associated 
with severe disease and foodborne outbreaks. In the future, a whole genome level 
comparative study could unveil the potential factors that contribute to O26:H11 as a 
STEC that can cause severe disease and foodborne outbreaks. A comparative 
genomic between O103:H2, O45:H2 and O111:H2 may also unveil the mechanism 
explaining why O103:H2 are much more associated with severe disease and 
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